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ABSTRACT
Cassani, Simone PhD, Purdue University, August 2016. Blood Circulation and Aque-
ous Humor Flow in the Eye: Multi-Scale Modeling and Clinical Applications. Major
Professor: Giovanna Guidoboni.
Glaucoma is a multi-factorial ocular disease associated with death of retinal gan-
glion cells and irreversible vision loss. Many risk factors contribute to glaucomatous
damage, including elevated intraocular pressure (IOP), age, genetics, and other dis-
eases such as diabetes and systemic hypertension. Interestingly, alterations in retinal
hemodynamics have also been associated with glaucoma. A better understanding of
the factors that contribute to these hemodynamic alterations could lead to improved
and more appropriate clinical approaches to manage and hopefully treat glaucoma
patients.
In this thesis, we develop several mathematical models aimed at describing ocular
hemodynamics and oxygenation in health and disease. Precisely we describe: (i) a
time-dependent mathematical model for the retinal circulation that includes macrocir-
culation, microcirculation, phenomenological vascular regulation, and the mechanical
effect of IOP on the retinal vasculature; (ii) a steady-state mathematical model for
the retinal circulation that includes macrocirculation, microcirculation, mechanistic
vascular regulation, the effect of IOP on the central retinal artery and central retinal
vein, and the transport of oxygen in the retinal tissue using a Krogh cylinder type
model; (iii) a steady-state mathematical model for the transport of oxygen in the
retinal microcirculation and tissue based on a realistic retinal anatomy; and (iv) a
steady-state mathematical model for the production and drainage of aqueous humor
(AH). The main objective of this work is to study the relationship between IOP, sys-
temic blood pressure, and the functionality of vascular autoregulation; the transport
xv
and exchange of oxygen in the retinal vasculature and tissue; and the production and
drainage of AH, that contributes to the level of IOP.
The models developed in this thesis predict that (i) the autoregulation plateau oc-
curs for different values of IOP in hypertensive and normotensive patients. Thus,
the level of blood pressure and functionality of autoregulation affect the changes in
retinal hemodynamics caused by IOP and might explain the inconsistent outcomes
of clinical studies; (ii) the metabolic and carbon dioxide mechanisms play a major
role in the vascular regulation of the retina. Thus, the impairment of either of these
mechanisms could cause ischemic damage to the retinal tissue; (iii) the multi-layer
description of transport of oxygen in the retinal tissue accounts for the effect of the
inner and outer retina, thereby improving the predictive ability of the model; (iv)
a greater reduction in IOP is obtained if topical medications target AH production
rather that AH drainage and if IOP-lowering medications are administrated to pa-
tients that exhibit a high initial level of IOP. Thus, the effectiveness of IOP-lowering
medications depend on a patient’s value of IOP.
In conclusion, the results of this thesis demonstrate that the insight provided by
mathematical modeling alongside clinical studies can improve the understanding of
diseases and potentially contribute to the clinical development of new treatments.
11. INTRODUCTION
1.1 The physiology of the eye
The eye is a complex structure composed of different parts, as depicted in Fig-
ure 1.1, that work together to achieve vision.
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Figure 1.1. Anatomy of the eye. By Rhcastilhos -
Schematic_diagram_of_the_human_eye_with_English_annotations.svg,
Public Domain, via Wikimedia Commons.
The sclera is the outermost part of the eye shell that protects the inner layers of
the eye. The choroid is the mid layer of the eye shell, located between the sclera and
the retina, that nourishes the outer part of the retina. The retina is the inner layer
of the eye shell that absorbs the light and sends the visual stimulus to the brain; it
2contains the macula and the fovea that are the regions responsible for visual acuity.
The ciliary body is located in the anterior part of the eye; it contains the ciliary
muscle and produces the aqueous humor (AH), a watery fluid that fills the space in
front of the lens, maintains the pressure inside the eye (intraocular pressure, IOP),
keeps the eye inflated and transports nutrients to the avascular regions of the eye.
The vitreous is a gel-like substance that fills the region behind the lens.
The main source of blood to the eye is the ophthalmic artery (OA), a branch
of the inner carotid artery. The major branches of the OA are the anterior ciliary
arteries (ACA), that nourish the ciliary body and the choroid, the central retinal
artery (CRA), that nourishes the inner part of retina, and the posterior ciliary arteries
(PCA), that nourish the choroid.
Posterior
short ciliary
artery
and vein
Sclera
Choroid
Retina
Lamina cribrosa
Bundles of
optic nerve
Central retinal artery and
central retinal vein
Figure 1.2. Optic nerve canal. The central retinal artery (CRA) and the
central retinal vein (CRV) run into the optic nerve canal piercing through
a collagen structure called lamina cribrosa (LC). Adapted from: by Henry
Vandyke Carter, Public Domain, via Wikimedia Commons, from [1], Plate
880.
3The CRA runs through the optic nerve canal, as depicted in Figure 1.2, piercing a
collagen structure called the lamina cribrosa (LC) that is responsible for maintaining
the pressure difference between the IOP (inside of the eye) and the retrolaminar tissue
pressure (in the optic nerve canal). When the CRA reaches the inside of the eyeball
it branches into 4 main retinal arteries. These vessels branch into smaller arteries,
arterioles, and capillaries that supply blood and nutrients to the retinal tissue. Blood
exits the capillaries and drains into venules, small veins, and the 4 major retinal veins.
These vessels converge into the central retinal vein (CRV) that runs through the optic
nerve canal parallel to the CRA, piercing the LC and converges into the ophthalmic
vein and cavernous sinus.
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Figure 1.3. Retinal blood flow response to changes in pressure (left) and
oxygen demand (right) in the case of normal retinal vascular regulation.
Under healthy conditions, the retina exhibits vascular regulation, which is the
ability to adjust perfusion in response to alterations in blood pressure or tissue oxy-
gen demand, as schematically represented in Figure 1.3. This change in perfusion is
achieved through vascular responses (eg. myogenic, shear stress, metabolic and car-
bon dioxide responses) to stimuli that affect the vascular tone of the smooth muscle
cells inside the wall of retinal arteries causing constriction or dilation of these walls.
41.2 Motivation
Alterations in retinal and retrobulbar hemodynamics are associated with many
ocular and systemic diseases, including glaucoma [2–4], age-related macular degen-
eration [5, 6] and diabetes [6, 7]. Furthermore, an elevated level of IOP has been
established as a risk factor for the prevalence, incidence and development of glau-
coma, a disease that is the second leading cause of blindness worldwide.
Since the retinal vasculature is in direct contact with IOP, it seems very likely
that IOP impacts retinal blood flow and velocity. However, clinical evidence of such
an impact is not unanimous. Several clinical studies have shown a decrease in retinal
and retrobulbar blood flow and velocity when IOP was increased [8–15], while other
studies did not find any significant changes in retinal and retrobulbar hemodynamics
with changes in IOP [16–28].
In the clinic, elevated IOP is treated with topical medications and/or with surgical
procedures, such as trabeculectomy.
IOP-lowering topical medications affect the production and/or drainage of AH,
and may alter retrobulbar hemodynamics. For example, studies found slightly in-
creased retrobulbar circulation in patients on these medications [8,12,13], while most
of the studies found that treatment with topical medications did not have a significant
effect on retrobulbar hemodynamics [16, 17,20–24,26–28].
During trabeculectomy surgery, IOP is reduced by removing part of the eye tra-
becular meshwork and adjacent structures, thereby increasing AH outflow. Most of
the hemodynamic measurements obtained after trabeculectomy provide evidence of
increased blood velocity as a result of lowering IOP [10,14,15]. However, other studies
did not report any significant change in blood velocity in the central retinal artery
after trabeculectomy [18,25].
Only a few studies have been conducted to evaluate the effect of IOP elevation on
ocular hemodynamics, and these have also provided variable results [9, 11, 19].
5It is hypothesized that in a disease state, some of the vascular regulation mecha-
nisms might be impaired, thereby compromising the oxygenation in the retina. How-
ever, there is inconsistency in the scientific literature regarding the vascular response
to changes in oxygen demand, as observed in flicker stimulation studies and light-dark
adaptation studies [29–36].
These inconsistent clinical observations are likely due to the numerous factors,
including arterial blood pressure [3, 37–41] and vascular regulation [3, 42–44], that
influence the relationship between IOP and ocular hemodynamics, and the intrinsic
difficulty of evaluating the individual contributions of these factors in a clinical setting.
Mathematical modeling can be used to investigate the complex relationship among
these factors and to interpret the outcomes of clinical studies.
In this perspective, the aims of this thesis are:
• To develop a reduced mathematical model for the retinal circulation that si-
multaneously accounts for (i) blood flow in the central retinal vessels; (ii) blood
flow in the retinal microcirculation; (iii) phenomenological retinal blood flow
regulation; (iv) biomechanical action of IOP on the retinal vasculature; and (v)
time-dependent arterial blood pressure. The model will be used to investigate
the relationship between IOP, blood pressure (BP) and vascular autoregulation
(AR) and the impact of these factors on retinal hemodynamics (Chapter 2).
• To characterize the difference between compressible and collapsible tubes that
are used to describe the wall deformation in arteries and veins (Section 2.1.5).
• To improve the description of vascular regulation in the model developed in
Chapter 2 by coupling it with an existing mechanistic model for retinal vascular
regulation (described in [45]). The model in [45] utilizes a Krogh-cylinder type
model to account for level of oxygen demand in the tissue. The resulting model
will include both the effect of IOP on the CRA and CRV, and the mechanistic
description of vascular regulation (Chapter 3).
6• To derive and implement a model for the transport of oxygen in the retinal
microvasculature and retinal tissue based on a physiological representation of:
(i) the retinal layers, (ii) the retinal vasculature, and (iii) the oxygen exchange
between the vasculature and the retinal tissue (Chapter 4).
• To investigate the processes that contribute to the level of IOP, and the uncer-
tainties in the outcomes of administration of IOP-lowering topical medication
using a model that describes the production and drainage of AH (Chapter 5).
72. MATHEMATICAL MODELING OF THE RETINAL
CIRCULATION
This Chapter introduces a mathematical model for the retinal circulation that simul-
taneously accounts for (i) blood flow in the central retinal vessels; (ii) blood flow in
the retinal microcirculation; (iii) retinal blood flow autoregulation; (iv) the biome-
chanical action of IOP on the retinal vasculature; and (v) time-dependent arterial
blood pressure. The model employs a hydraulic analogy to Ohm’s law in which blood
flow in the central retinal vessels and retinal microvasculature is analogous to the cur-
rent flowing through a network of resistances and capacitances. Variable resistances
describe active and passive diameter changes due to blood flow autoregulation and
IOP. Systemic arterial BP is an input to the model. Model outputs include total
retinal blood flow and blood velocity in the CRA, CRV and microvasculature, which
are compared with clinically-measurable quantities.
In Section 2.1 the model and its governing equations are described; in Section 2.2
the algorithm to perform numerical simulations is defined; in Section 2.3 the mathe-
matical model is used to understand the relationships among IOP, BP, autoregulation
and retinal and retrobulbar hemodynamics, and to investigate the effect of trabeculec-
tomy on retinal hemodynamics. In Section 2.4 the results are discussed and compared
with clinical data. The material and results presented in this Chapter are partially
published in [46,47]
2.1 Methods
The retinal circulation is described using the analogy between the flow of a fluid
in a hydraulic network and the flow of current in an electric circuit, as depicted in
Figure 2.1. The vasculature supplying the retina is divided into five main compart-
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Figure 2.1. Network model for the retinal vasculature. The vasculature
is divided into five main compartments: the central retinal artery (CRA),
arterioles, capillaries, venules, and the central retinal vein (CRV). Each
compartment includes resistances (R) and capacitances (C). The intraoc-
ular segments are exposed to the IOP, the retrobulbar segments are ex-
posed to the RLTp, and the translaminar segments are exposed to an
external pressure that depends on the internal state of stress within the
lamina cribrosa (gray shaded area). Diameters of venules and intraocular
and translaminar segments of the CRA and CRV are assumed to vary
passively with IOP, whereas arterioles are assumed to be vasoactive.
ments: the CRA, arterioles, capillaries, venules, and the CRV. Using the analogy
between hydraulic and electrical circuits, blood flow is modeled as current flowing
through a network of resistors (R), representing the resistance to flow offered by
blood vessels, and capacitors (C), representing the ability of blood vessels to deform
and store blood volume. Resistors and capacitors have been labeled with numbers
from 1 to 5 to distinguish between compartments, and additional alphabetic labels
are used to distinguish between segments within the same compartment. For exam-
ple, the CRA compartment is referenced by the label 1 and it includes a retrobulbar
9segment with resistances R1a and R1b, a translaminar segment with resistance R1c,
and an intraocular segment with resistance R1d. We remark that the resistance of
the retrobulbar segment is split into R1a and R1b to allow the capacitance C1 to act
on the mean pressure of the retrobulbar portion of the CRA (P1). The blood flow
through the retinal vascular network is driven by Pin and Pout, which represent the
BPs upstream of the CRA and downstream of the CRV, respectively. The vascular
segments are exposed to various external pressures depending on their position in
the network. The intraocular segments are exposed to the IOP, the retrobulbar seg-
ments are exposed to the retrolaminar tissue pressure (RLTp), and the translaminar
segments are exposed to an external pressure that depends on the internal state of
stress within the lamina cribrosa. The IOP-induced stress within the lamina cribrosa
is computed using a nonlinear elastic model described in [48]. The resistances of the
venules and intraocular and translaminar segments of the CRA and CRV are assumed
to vary passively with IOP, as detailed in Section 2.1.5. Arteriolar resistance varies
actively to maintain a relatively constant blood flow despite changes in the ocular
perfusion pressure (OPP). Ocular perfusion pressure is defined as OPP= (2/3) MAP
− IOP, where MAP is the mean arterial pressure at the level of the brachial artery,
MAP= (2/3)DP +(1/3) SP, and DP and SP are diastolic and systolic arterial BPs,
respectively. The arrows in Figure 2.1 indicate the resistors that vary passively or
actively.
2.1.1 Governing equations
Ohm’s law states that the flow Q through a resistor is directly proportional to the
pressure drop ∆P across the resistor, with a proportionality constant that is equal to
the reciprocal of the resistance, namely
Q =
∆P
R
. (2.1)
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The flow Q through a capacitor is directly proportional to the time derivative of the
product between the pressure drop across the capacitor and the capacitance, namely
Q =
d
dt
(C∆P ) . (2.2)
Here, capacitance is assumed constant so (2.2) becomes
Q = C
d∆P
dt
. (2.3)
By Kirchoff’s law, the following relationship must hold at every node in the network:
volume change = flow in− flow out. (2.4)
The application of Kirchoff’s law to the retinal vascular network shown in Figure 2.1
leads to the following system of ordinary differential equations for the nodal pressures
P1, P2, P4, P5:
C1
d(P1 − RLTp)
dt
=
Pin − P1
Rin +R1a
− P1 − P2
R1b +R1c +R1d +R2a
C2
d(P2 − IOP)
dt
=
P1 − P2
R1b +R1c +R1d +R2a
− P2 − P4
R2b +R3a +R3b +R4a
C4
d(P4 − IOP)
dt
=
P2 − P4
R2b +R3a +R3b +R4a
− P4 − P5
R4b +R5a +R5b +R5c
C5
d(P5 − RLTp)
dt
=
P4 − P5
R4b +R5a +R5b +R5c
− P5 − Pout
R5d +Rout
.
(2.5)
The inlet and outlet pressures Pin and Pout vary with time along a cardiac cycle and,
consequently, the pressures calculated via equation (2.5) are time dependent.
The remaining nodal pressures in the circuit of Figure 2.1 can be computed via Ohm’s
law in the corresponding segments.
2.1.2 Control state
A control state for the system is defined to represent typical conditions of a healthy
eye. Control values of any given quantity will be indicated with an overline bar.
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External and systemic pressures
We assume that for a healthy individual IOP = 15 mmHg [49–51], RLTp = 7
mmHg [52,53], SP = 120 mmHg, and DP = 80 mmHg.
Retinal blood flow
The control value Q of the retinal blood flow can be estimated by applying
Poiseuille’s law to the CRA, since the CRA is the only vessel supplying blood to
the retinal vascular network. In the hypotheses of laminar flow and cylindrical geom-
etry, Poiseuille’s law yields Q = piV cra,maxD2cra/8, where Dcra is the CRA diameter,
and V cra,max is the average value of the CRA centerline velocity over a cardiac cycle.
Measurements from human patients are used to define the control state values for
Dcra = 175 µm [54], and V cra,max = 5.67 cm/s [11, 54], which yield a physiological
value of Q = 6.8178 · 10−4 mL/s [54–58].
Resistance
According to Poiseuille’s law, the resistance of a vessel is
R =
128µL
piD4
, (2.6)
where D is the vessel diameter, L is the vessel length and µ is blood viscosity. Using
this law and the geometric and physical parameters for the CRA and CRV reported
in Table 2.1, the control state values of the CRA and CRV resistances are computed
and summarized in Table 2.2.
Determining the control state values of arteriolar, capillary, and venular resistance
is more complex, because these compartments include a hierarchy of numerous vessels
of various diameter. We adapt the dichotomous network (DN) model for the retinal
microcirculation proposed in [59] to describe the hierarchical architecture of arterioles,
capillaries, and venules. The DN model includes 14 levels of arterioles, 1 level of
capillaries, and 14 levels of venules; each level includes a specific number of identical
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Table 2.1.
Geometric and physical parameters for the CRA and CRV.
CRA CRV
Parameters Value Source Value Source
Diameter D, µm 175 [54] 238 [59]*
Length L, mm, total 10 [60] 10 [60]
Segment a 4.4 [60] 1 [61]
Segment b 4.4 [60] 0.2 [62, 63]
Segment c 0.2 [62, 63] 4.4 [60]
Segment d 1 [61] 4.4 [60]
Blood viscosity µ, cP 3.0 [64, 65] 3.24 [59]**
Wall Young’s modulus E, MPa 0.3 [65–67] 0.6 [68]
Wall Poisson’s ratio ν 0.49 [66, 67] 0.49 ***
Wall thickness h, µm 39.7 [65, 69] 10.7 [70]
*CRA/CRV diameter ratio is assumed to be the same as that for the first generation
arteries/veins in [59].
**Blood viscosity in the CRV is assumed to be 8% larger than that in the CRA (as in [59]).
***Poisson’s ratio of the CRV wall is assumed to be the same as that for the CRA wall.
parallel vessels. In our model, we characterize these 29 vascular levels into arterial,
capillary and venous compartments according to vessel size. Vessels with diameter
less than 6.5 µm are defined as capillaries, as shown in Figure 2.2. Vessel number,
diameter, length, and blood viscosity for the 29 levels in the DN model are reported
in Table 2.3 and the corresponding values of the lumped resistances calculated in the
control state are summarized in Table 2.2. It is important to note that the viscosity
values used in the model are effective viscosity values that are based on an empirical
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Table 2.2.
Computed values of the vascular resistances at the control state.
Resistance
Value,
Resistance
Value,
mmHg · s/mL mmHg · s/mL
Rin 2.25 · 104 R3b 5.68 · 103
R1a 4.30 · 103 R4a 3.11 · 103
R1b 4.30 · 103 R4b 3.11 · 103
R1c 1.96 · 102 R5a 3.08 · 102
R1d 9.78 · 102 R5b 6.15 · 101
R2a 6.00 · 103 R5c 1.35 · 103
R2b 6.00 · 103 R5d 1.35 · 103
R3a 5.68 · 103 Rout 5.74 · 103
relationship and that depend on vessel diameter. In this way, the model takes into
account the corpuscular nature of blood.
Our model
arterioles capillaries venules
DN model
1art . . . 12art13art14art cap. 14ven13ven . . . 1ven
diameter < 6.5µm
Figure 2.2. Relationship between the DN model by Takahashi et al. [59]
and the chosen geometry of our model. The 29 vascular levels of the DN
model have been divided into three model compartments for arterioles,
capillaries, and venules according to vessel size.
Rin and Rout represent the ocular vessels upstream of the CRA and downstream
of the CRV. Their control values are determined by the control value Q of the total
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Table 2.3.
Geometric and physical parameters used in the computation of control
state resistances for the arterioles, capillaries and venules compartments
in the control state. Adapted from [59].
Arterioles in [59] Venules in [59]
Level Number Diameter Length Blood Level Number Diameter Length Blood
of vessels D, µm L, µm viscosity µ, cP of vessels D, µm L, µm viscosity, µ, cP
1 1 108.0 726.9 3.7 1 1 147.0 1036.2 4.2
2 2 84.7 549.6 3.6 2 2 115.3 783.4 4.0
3 4 66.4 415.5 3.4 3 4 90.4 592.3 3.9
4 8 52.1 314.1 3.2 4 8 70.9 447.8 3.7
5 16 40.8 237.5 2.9 5 16 55.6 338.5 3.5
6 32 32.0 179.5 2.7 6 32 43.6 255.9 3.2
7 64 25.1 135.5 2.4 7 64 34.2 193.5 3.0
8 128 19.7 102.6 2.1 8 128 26.8 146.3 2.7
9 256 15.4 77.6 1.8 9 256 21.0 110.6 2.3
10 512 12.1 58.7 1.5 10 512 16.5 83.6 2.0
11 1024 9.5 44.3 1.2 11 1024 12.9 63.2 1.7
12 2048 7.4 33.5 0.9 12 2048 10.1 47.8 1.4
13 4096 5.8 25.3 2.5 13 4096 7.9 36.1 1.1
14 8192 5.1 21.7 4.2 14 8192 6.2 27.3 2.8
cap. 32768 5.0 500.0 4.6
The dashed line shows the division of the 29 vascular levels from [59] into the arterioles,
capillaries and venules compartments in our model, as depicted in Figure 2.2.
retinal blood flow and the control value of the pressures P in, P 1,in, and P out, P 5,out
(defined below).
Pressure
The control value of the input pressure for this model is chosen to be two-thirds
of the MAP measured at the level of the brachial artery, where the factor two-thirds
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Table 2.4.
Computed values of intraluminal blood pressure at the control state.
Pressure
Value,
Pressure
Value,
mmHg mmHg
P in 62.22 P 3,4 24.25
P 1,in 46.85 P 4 22.13
P 1 43.92 P 4,5 20.01
P 1,pre 40.99 P 5,post 19.80
P 1,post 40.85 P 5,pre 19.76
P 1,2 40.19 P 5 18.84
P 2 36.09 P 5,out 17.92
P 2,3 32.00* P out 14.00**
P 3 28.13
*This value chosen based on previous studies [45,71].
**This value is chosen to be less than P 5,out and higher than the jugular venous pressure
(' 4− 6 mmHg [72]).
accounts for the drop in pressure between the brachial artery and the eye [73]. Since
SP = 120 mmHg and DP = 80 mmHg, it follows that P in = 62.2 mmHg, as
reported in Table 2.4. The control pressure between arterioles and capillaries, P 2,3,
is set at 32 mmHg [45, 71]. The control pressures at all the other nodes of the
network are computed using Ohm’s law and the control values of the resistances,
namely P i = P j − Ri,jQ, where the subscripts i and j indicate any two consecutive
nodes and Ri,j indicates the resistance between them. The control value of the outlet
pressure is chosen to be P out = 14 mmHg, so that it is less than P 5,out and higher
than the jugular venous pressure (normally between 4 and 6 mmHg [72]). All control
pressures are summarized in Table 2.4.
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Table 2.5.
Computed values of vascular volume and capacitance at the control state.
Segment Volume, mL Capacitance, mL/mmHg
CRA 2.12 · 10−4 7.22 · 10−7
Arterioles 2.20 · 10−4 7.53 · 10−7
Venules 6.12 · 10−4 1.67 · 10−5
CRV 3.92 · 10−4 1.07 · 10−5
Capacitance
The capacitance of a vessel represents its ability to store fluid volume for a given
pressure difference between the inside and outside of the vessel. The capacitance of
vascular compartments can be computed as the product of vascular volume (V ol)
and distensibility (Dist) [74]. The control values of the CRA and CRV volumes
are computed as V olcra = piD2craLcra/4 and V olcrv = piD2crvLcrv/4. Analogously, the
control values of the volumes of arterioles, capillaries, and venules are computed by
using the diameters and lengths reported in Table 2.3. The distensibilities of the CRA
and the retinal arterioles are assumed to be equal to those of the cerebral arteries [74],
namely Distcra = Dist2 = 34.12·10−4 mmHg−1. The distensibilities of retinal venules
and the CRV are assumed to be eight times larger than those of the arteries, namely
Distcrv = Dist4 = 27.30 · 10−3 mmHg−1 [74]. The control volumes and capacitances
are reported in Table 2.5.
2.1.3 Time-profiles of the input and output pressure waves
The time profile of Pin and Pout at the control state are determined through an
inverse problem based on color Doppler imaging measurements of blood velocity in
the CRA and CRV, as shown in Figure 2.3a. The centerline blood velocity V (t) in the
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CRA and CRV is given by V (t) = 8Q(t)/piD2 , where Q(t) = ∆P (t)/R(t) and ∆P (t)
is the pressure drop along the resistor. Thus, equation (2.5) can be used to determine
the time profiles Pin(t) and Pout(t) that give the CRA blood velocity profiles shown in
Figure 2.3b when the system is at its control state. The control profiles of P in(t) and
P out(t) are shown in Figure 2.3c, and their mean values are P in = 62.2 mmHg and
P out = 14 mmHg. At the control state, the maximum and minimum values of P in(t)
are P in,max = 92.2 mmHg and P in,min = 39.6 mmHg, and their ratios with respect
to SP and DP are P in,max/SP = 0.7683 and P in,min/DP = 0.4945. These ratios are
used to scale the Pin(t) profile in the simulations of clinical conditions where SP and
DP are different from their control state values.
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Figure 2.3. (a) Typical color Doppler imaging (CDI) measurement of
the blood velocity in the CRA and CRV. (b) Time profiles of the blood
velocity in the CRA and CRV at the control state. (c) Time profile of the
inlet and outlet pressures P in(t) and P out(t) at the control state.
2.1.4 IOP-induced stress in the lamina cribrosa
The lamina cribrosa is modeled as a nonlinear, homogeneous, isotropic, elastic
circular plate of radius rlc and finite thickness hlc, satisfying the equilibrium equation,
∇ · S = 0, where
S = λlc(σe)tr(E)I+ 2µlc(σe)E (2.7)
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is the stress tensor,
E =
[
∇v + (∇v)T + (∇v)T ∇v
]
2
(2.8)
is the Green-Saint Venant strain tensor, v is the displacement vector, µlc is the shear
modulus,
λlc = µlc
Elc − 2µlc
3µlc − Elc (2.9)
is the Lamé’s parameter, and Elc is the Young’s modulus. The elastic parameters λlc
and µlc vary with the effective stress σe, as described by Guidoboni et al. [48,75] and
in Table 2.7.
Table 2.6.
Radius and thickness values used in the mathematical model for the lam-
ina cribrosa and sclera
Parameter Value Source
Radius of the lamina cribrosa rlc, mm 0.75 [76]
Thickness of the lamina cribrosa hlc, mm 0.2 [62,63]
Radius of the sclera rs, mm 12 [62,77]
Thickness of the sclera hs, mm 1 [63,77]
Table 2.7.
Model values of Young’s modulus Elc and shear modulus µlc for the lamina
cribrosa as a function of the effective stress σe, as in [78,79].
Elc, MPa µlc, MPa Range of σe, MPa
0.358 0.12 0.000 ≤ σe < 0.008
0.656 0.22 0.008 ≤ σe < 0.0015
1.818 0.61 σe ≥ 0.015
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The problem is solved in cylindrical coordinates, as shown in Figure 2.4, with
the boundary conditions Sn = −IOPn at ζ = hlc/2, Sn = −RLTpn at ζ = −hlc/2,
nSn = T and vζ = 0 at s = rlc, where T is the scleral tension computed via Laplace’s
law
T =
IOP rs
2hs
, (2.10)
where rs and hs are the radius and thickness of the sclera, respectively.
ζ
s
θ
IOP
RLTp
hlc
rlc
ζ
sT
IOP
RLTp
Figure 2.4. Schematic representation of geometry and boundary condi-
tions of the elasticity problem for the lamina cribrosa. The anterior sur-
face (ζ = hlc/2) is subject to the intraocular pressure (IOP), while the
posterior surface (ζ = −hlc/2) is subject to the retrolaminar tissue pres-
sure (RLTp). The lateral surface (s = rlc ) is connected to the sclera and
experiences the scleral tension T .
Geometrical and mechanical properties of the lamina and sclera are summarized
in Tables 2.6 and 2.7; the numerical solution of the elastic problem via finite elements
is described in Guidoboni et al. [48]. The radial component of the normal stress Sss at
s = 0 resulting from the solution of this elastic problem is assumed to be the external
pressure, PLC(ζ), acting on the intralaminar segments of the CRA and CRV, which
are assumed to pierce the lamina in its center [48].
2.1.5 Variable passive resistance
In this Section, the mechanical response of the vessels to changes in the value of
transmural pressure difference is modeled.
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Consider a straight cylinder Ω with cross-section Σ (with general shape, thus
not necessarily cylindrical) and length L in a Cartesian coordinate system (x, y, z), as
shown in Figure 2.5; that is Ω = Σ×(0, L). Let ex, ey and ez be the unit vectors in the
x, y and z (axial) direction, respectively. Let’s remark that an equivalent formulation
could be obtained using other coordinate restrictions (e.g. polar coordinates).
x
y
z Σ
z = 0 z = L
Figure 2.5. Representative cylinder Ω in the Cartesian coordinate system
(x, y, z) with cross-section Σ, of length L.
Let us assume that the motion inside the cylinder Ω can be described by the
stationary Navier-Stokes equations:
∇ · u = 0, in Ω
(u · ∇)u = −1
ρ
∇p+ µ
ρ
∆u, in Ω
u = 0, on ∂Σ× (0, L)
p(z = 0) = p0, p(z = L) = pL,
(2.11)
where u is the fluid velocity, p is the fluid pressure, ρ is the fluid density and µ is the
fluid dinamic viscosity, ∇· is the divergence operator, ∇ is the gradient operator, ∆ is
the Laplacian operator and the boldface variables are vectorial quantities. We remark
that ρ and µ are assumed to be given positive constants. The third equation in (2.11)
represents the no-slip boundary condition. In particular this boundary condition
could also be interpreted as
u =
 uΣ · nΣ = 0, on ∂Σ× (0, L)uz = 0, on ∂Σ× (0, L), (2.12)
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where u = uΣ + uzez, with uΣ = uxex + uyey, and nΣ is the outward normal vector
to ∂Σ× (0, L).
The value of the pressure is assigned at the inlet and at the outlet of the cylinder
in (2.11).
Starting from (2.11), we will perform a model reduction using the following as-
sumptions:
• body forces and mass sources are absent;
• p is constant on each Σ ⇒ p = p(z);
• uz = u(z)f(Σ), where u(z) represents the average axial velocity on the cross-
section Σ and f(Σ) is an appropriate shape function;
• axial motion is predominant, thus |uΣ|  uz.
A model reduction is performed by integrating the equations in system (2.11) on
the cross-section Σ. Although not applied here, it is worth mentioning that a more
sophisticated analysis can be obtained by integrating over the infinitesimal volume
Σ× (z − dz, z + dz) with dz → 0, as shown in [80].
Define Q(z) =
∫
Σ
uz dσ = u(z)A(z) , and A(z) =
∫
Σ
1 dσ to be the volumetric
average flow rate and the cross-sectional area, respectively. Note that the first equality
together with the definition of uz implies that
∫
Σ
f(Σ) dσ = A(z).
We begin considering the first equation in (2.11), and we split the divergence
operator is into its transversal and axial components to emphasize the contribution
of the different directions of motion
∇ · u = ∇Σ · uΣ + ∂uz
∂z
, with ∇Σ · uΣ = ∂ux
∂x
+
∂uy
∂y
. (2.13)
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Then, integrating over the cross-section, we obtain:
0 =
∫
Σ
∇ · u dσ =
∫
Σ
∇Σ · uΣ dσ +
∫
Σ
∂uz
∂z
dσ
1
=



∫
∂Σ
uΣ · nΣ dγ +
∫
Σ
∂uz
∂z
dσ
2
=
d
dz
∫
Σ
uz dσ −
∫
∂Σ
(u · nΣ)uz dγ
=
d
dz
∫
Σ
u(z)f(Σ) dσ −



∫
∂Σ
(uΣ · nΣ)uz dγ −



∫
∂Σ
(uzez · nΣ)uz dγ
3
=
d
dz
u(z)
∫
Σ
f(Σ) dσ =
d
dz
(
u(z)A(z)
)
=
dQ(z)
dz
,
(2.14)
where, in step 1, the contribution of the cross-sectional component of the operator is
moved to the boundary of Σ using the divergence theorem and then it is eliminated
due to the boundary conditions; in step 2, the partial derivative with respect to z
is moved outside of the integral using Leibniz theorem and it is changed to a total
derivative; in step 3, u(z) is moved outside of the integral since the integration does
not depend on the axial coordinate z.
The advective term of the momentum equation in (2.11) can be written as:
u · ∇u = ∇ · (u⊗ u)−u∇ · u, (2.15)
where the operator ⊗ represents the outer product.
Integrating the second equation in (2.11) on the cross-section Σ and applying the
identity (2.15), we obtain:∫
Σ
∇ · (u⊗ u) dσ + 1
ρ
∫
Σ
∇p dσ − µ
ρ
∫
Σ
∆u dσ = 0. (2.16)
Since the contribution of axial motion is predominant and pressure is assumed to be
constant on each cross-section Σ, it is possible to focus only on the z−component of
equation (2.16), namely∫
Σ
∇ · (uz ⊗ u) dσ + 1
ρ
∫
Σ
∂p
∂z
dσ − µ
ρ
∫
Σ
∆uz dσ = 0. (2.17)
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The first integral in (2.17) becomes
∫
Σ
∇ · (uz ⊗ u) dσ =
∫
Σ
∇Σ · (uzuΣ) dσ +
∫
Σ
∂u2z
∂z
dσ
1
=
∫
∂Σ
uzuΣ · nΣ dγ +
∫
Σ
∂
(
u2(z)f 2(Σ)
)
∂z
dσ
2
=



∫
∂Σ
uzuΣ · nΣ dγ + du
2(z)
dz
∫
Σ
f 2(Σ) dσ
= βA(z)
du2(z)
dz
, where β def=
1
A(z)
∫
Σ
f 2(Σ) dσ,
(2.18)
where in step 1 the first integral on the right hand side is moved to the boundary using
the divergence theorem, and in step 2 the boundary condition in (2.11) is applied.
The second integral in (2.17) becomes
1
ρ
∫
Σ
∂p
∂z
dσ =
1
ρ
dp
dz
∫
Σ
dσ =
A(z)
ρ
dp
dz
. (2.19)
The third integral in (2.17) becomes
−µ
ρ
∫
Σ
∆uz dσ = −µ
ρ
∫
Σ
∆Σuz dσ − µ
ρ
∫
Σ
∂2uz
∂z2
dσ
1
= −µ
ρ
∫
Σ
∇Σ · (∇Σuz) dσ −



*' 0
µ
ρ
∫
Σ
∂2uz
∂z2
dσ
= −µ
ρ
u(z)
∫
Σ
∇Σ ·
(∇Σf(Σ)) dσ
= −µ
ρ
u(z)
∫
∂Σ
nΣ · ∇Σf(Σ) dγ
= Kru(z), where Kr
def
= −µ
ρ
∫
∂Σ
nΣ · ∇Σf(Σ) dγ,
(2.20)
where in step 1 the contribution of diffusion in the axial direction is neglected.
Combining (2.14), (2.18), (2.19), and (2.20), the following system of equations is
obtained: 
dQ(z)
dz
= 0, in (0, L)
βA(z)
du2(z)
dz
+
A(z)
ρ
dp
dz
+Kru(z) = 0, in (0, L).
(2.21)
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Due to the low Reynolds number (Re ' 4 in the CRA), the second equation of (2.21)
becomes



βA(z)
du2(z)
dz
+
A(z)
ρ
dp
dz
+Kru(z) = 0, (2.22)
or equivalently
1
Krρ
dp
dz
+
Q(z)
A2(z)
= 0. (2.23)
The value ofKr depends on the specific profile f(Σ) that is chosen a priori for the fluid
motion. In the case of a parabolic velocity profile (Poiseuille’s flow)Kr =
8piµ
ρ
[80,81].
Equation (2.23) involves the volumetric flow Q(z) and the pressure gradient along
the tube
dp
dz
and, consequently, the vascular resistance (Ohm’s Law). However, the
problem of how to introduce the contribution of the transmural pressure difference
to the resistance is not well-defined. The problem is closed by introducing the tube
law [81–84],
P (α) =
p(z)− pe
Kp
. (2.24)
In equation (2.24), α def=
A(z)
Aref
represents the ratio between the cross-sectional area
A(z) and the reference cross-sectional area Aref , p(z) represents the pressure inside the
tube, and pe represents the external pressure acting on the tube, respectively. Thus,
equation (2.24) relates the effect of transmural pressure difference (i.e. p(z) − pe)
with the mechanical response of the vessel. The value of the constant Kp is chosen
in agreement with the value in [81,84] for a linear elastic tube.
Kp
def
=
E
12(1− ν2)
(
h
rref
)3
, (2.25)
where E, ν and h are the tube Young’s modulus, Poisson’s ratio and wall thickness
respectively.
Notice that the reference state corresponds to p− pe = 0 and a circular cross-section,
and thus Aref = pir2ref where rref is the reference state radius of the tube. If p−pe > 0,
the cross-section will dilate, corresponding to α > 1, and if p−pe < 0, the cross-section
will constrict, corresponding to α < 1.
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The explicit form of P (α) depends on the physiological and mechanical properties
of the considered tube. Arterial walls are thicker than venous walls, and the pressure
inside of an arterial branch is usually higher than in the corresponding venous branch.
Therefore arteries can be described as compressible tubes that will deform but will
unlikely collapse. Veins can be described as collapsible tubes which may be subject
to a negative transmural pressure difference and are more likely to collapse. The
phenomenon of venous collapse is known as Starling resistor.
pe
p
Σ
rref + η
rref
Figure 2.6. Radial displacement on cross-section Σ in the case of a com-
pressible tube for a positive transmural pressure difference p− pe > 0.
For the case of a compressible tube, the cross-section is assumed to remain circular
and the radial displacement η is computed using Laplace’s law
η =
(1− ν2)r2ref (p− pe)
Eh
. (2.26)
Some algebraic manipulations are then necessary to introduce P (α) in the equation.
η =
(1− ν2)r2ref (p− pe)
Eh
=
h2
12rref
12(1− ν2)
E
(
rref
h
)3
(p− pe)
=
h2
12rref
p− pe
Kp
=
h2
12r2ref
p− pe
Kp
rref =
h2
12r2ref
P (α)rref =
rref
kL
P (α),
where kL = 12
(
rref
h
)2
.
(2.27)
Thus P (α) = kL
η
rref
. In addition
A = pir2 = pi(rref + η)
2, Aref = pir
2
ref ,
rref + η =
√
A/pi, rref =
√
Aref/pi,
(2.28)
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and
η
rref
=
rref + η
rref
− rref
rref
=
√
A/pi√
Aref/pi
− 1 = α1/2 − 1. (2.29)
So P (α) = kL(α1/2 − 1).
α
p− pe
1
ε−band
Figure 2.7. Graph of tube law experimental results for a collapsible tube,
adapted from [81–84]. The cross-section shape changes from circular to
elliptic to highly collapsed as the transmural pressure difference p − pe
decreases.
For the case of a collapsible tube, when α < 1, the corresponding tube law is
P (α) = 1 − α−3/2. This formula is based on experiments [81, 84] and describes the
Starling resistor effect, graphically depicted in Figure 2.7. When the transmural
pressure difference is positive, the vessel is dilating and thereby maintaining a cir-
cular cross-section. However, when the transmural pressure difference is negative,
the cross-section becomes elliptical. In this region, known as ε−band, as shown in
Figure 2.7, small changes in transmural pressure difference yield large changes in the
cross-sectional area (and in the vascular resistance). As the transmural pressure dif-
ference becomes more negative, the vessel continues to collapse until two opposite
sides of the inner wall touch each other. In this region, the vessel is more resistant
and thus large changes in the transmural pressure difference yield small changes in
the cross-sectional area (and in the vascular resistance).
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The modeling choices adopted for P (α) for a compressible and collapsible tube
are summarized below.
Compliant tube P (α) = kL(α1/2 − 1),
Collapsible tube P (α) =
 1− α
−3/2, α ≤ 1
kL(α
1/2 − 1), α > 1.
The last step necessary to close the problem is to use the tube law to find an
explicit formulation for the vascular resistance. The case for the collapsible tube will
be shown in detail. The computations for compressible tubes are the same as those
for the collapsible tubes when α > 1.
First, the tube law can be solved for α:
α =

[
1− P (α)]−2/3 , α ≤ 1
[
P (α)
kL
+ 1
]2
, α > 1
=

[
1− p(z)− pe
Kp
]−2/3
, α ≤ 1
[
p(z)− pe
KpkL
+ 1
]2
, α > 1.
(2.30)
Then, equation (2.23) is integrated from z = 0 to z = L (note that the first
equation in (2.21) implies that Q does not depend on z) to obtain an equation for
the resistance:
1
Krρ
dp
dz
+
Q
A2(z)
= 0
1
Krρ
∫ L
0
dp
dz
dz = −Q
∫ L
0
1
A2(z)
dz
pL − p0
Krρ
= − Q
A2ref
∫ L
0
α−2 dz
p0 − pL
Q
=
Krρ
A2ref
∫ L
0
α−2 dz
R =
Krρ
A2ref
∫ L
0
α−2 dz.
(2.31)
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Finally the expression for α (2.30) is substituted into this expression for the resistance
to obtain
R =

Krρ
A2ref
∫ L
0
[
1− p(z)− pext
Kp
]4/3
dz ' KrρL
A2ref
[
1− pˆ− pext
Kp
]4/3
, α ≤ 1
Krρ
A2ref
∫ L
0
[
p(z)− pext
KpkL
+ 1
]−4
dz ' KrρL
A2ref
[
pˆ− pext
KpkL
+ 1
]−4
, α > 1,
(2.32)
where the value of the pressure p(z) is approximated by the average pressure pˆ inside
the vessel, namely p ' pˆ = p0 + pL
2
.
The compliant tube case gives the analogous result
R =
KrρL
A2ref
[
p− pext
KpkL
+ 1
]−4
. (2.33)
It is also possible to check that the modeling approach used in the compliant tube
case is equivalent to Poiseuille’s Law
R =
KrρL
A2ref
[
p− pext
KpkL
+ 1
]−4
=
8piµρL
ρpi2r4ref
[
P (α)
kL
+ 1
]−4
(2.27)
=
8µL
pir4ref
[
η
rref
+ 1
]−4
=
8µL
pir4ref
[
η + rref
rref
]−4
=
=
8µL
pir4ref
[
r
rref
]−4
=
8µL
pir4
=
128µL
piD
,
(2.34)
where r and D represent the tube radius and diameter, respectively.
The compliant tube case is used to compute the resistances R1c and R1d (Fig-
ure 2.1), while the collapsible tube case formula is used to compute the resistances
R4a, R4b, R5a and R5b. The value of the external pressure pe varies depending on the
region in which the resistance is positioned (pe = IOP in the intraocular region and
pe = PLC(ζ) in the translaminar region).
The physical parameters of the segments in the venules compartment used in the
computation of R4a and R4b are chosen as follows: the values of the wall-to lumen-ratio
at control state and the Poisson’s ratio are h/D = 0.05 and ν = 0.49, respectively,
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where h represents the thickness of the vessel wall and D is the diameter. These
values are the same as the values in the CRV. The value of the Young’s modulus is
E = 0.066 MPa.
2.1.6 Active variable resistance
The resistances R2a and R2b are modeled through a phenomenological description
of blood flow autoregulation, following the method utilized by Lakin et al. in the
context of cerebral blood flow [74]. The absence of autoregulation is modeled by
keeping the arteriolar resistances R2a and R2b constantly equal to their control value
R2a and R2b, respectively, despite changes in OPP, while functional autoregulation is
modeled by allowing the arteriolar resistances to vary according to the formula:
R2a = R2b = R2a
cL + cU exp
[
K
(
QnoAR(OPP)−Q
)
− cˆ
]
1 + exp
[
K
(
QnoAR(OPP)−Q
)
− cˆ
] , (2.35)
where cL = 2.5 · 10−3 and cU = 1.18 determine the lower and upper bounds for
the resistance, K = 3.45 · 104 s/mL determines the sensitivity of vessel resistance to
changes in OPP, QnoAR is the total retinal blood flow predicted by the model in the
absence of autoregulation for a given OPP and cˆ = ln(cU−1)− ln(1−cL) ensures that
R2a = R2a and R2b = R2b at the control state. The numerical values of cL, cU and K
have been chosen to yield an increase in resistance over the range of OPP depicted
in Figure 2.8a. Model simulations of normalized flow in the case of functional and
absent autoregulation are reported in Figure 2.8b for various OPP values (attained
by setting IOP = 15 mmHg and varying MAP between 63 and 123 mmHg).
Figure 2.10c shows that the model predicted values of retinal blood flow in the
case of functional autoregulation are consistent with clinical measurements for var-
ious MAP levels; this suggests that formula (2.35) and its related assumptions are
appropriate modeling choices for retinal blood flow autoregulation.
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Figure 2.8. Arteriolar resistance (a) and normalized flow (b) for model
simulations with functional (solid line) or absent (dashed line) autoreg-
ulation for various ocular perfusion pressures (OPP) attained by setting
IOP = 15 mmHg and varying MAP.
2.2 Solution algorithm
In this Section we illustrate the solution procedure for the nonlinear problem
in system (2.5). The nonlinearities of the system are due to the variable passive
resistances that are highly nonlinear functions of the nodal pressures in Figure 2.1.
To address these numerical difficulties, the problem is linearized and solved with an
iterative algorithm using the fixed point method as described below:
Given the values of IOP, RLTp, SP, DP, and an initial guess for each nodal pressure
in Figure 2.1
P 0,0j , for j ∈ H def=
{
(in), (1, in), (1), . . . , (5), (5, out), (out)
}
. (2.36)
Then, let n = 0, . . . , N be the nodes of the time discretization of a cardiac cycle:
• Step 1:
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Figure 2.9. Schematic representation of the translaminar portion of the
central retinal vessels.
– Update P nin to be consistent with the given values of SP and DP
– Solve the lamina cribrosa problem in [48] to obtain the value of PLC(ζ),
with ζ ∈
[
−hLC
2
,
hLC
2
]
– Set
R2a = R2b =
 R2a, if AR is absent(2.35), if AR is functional; (2.37)
for k ≥ 0
• Step 2: For n = 1, . . . , N
– Compute Rn,k1c using a modified version of formula (2.33) that includes the
variation along the coordinate ζ of the value of PLC as shown in Figure 2.9.
Rn,k1c =
Krρ
A2ref
∫ hLC/2
−hLC/2
[
Pˆ − PLC(ζ)
KpkL
+ 1
]−4
dζ, (2.38)
where Pˆ =
(
P n−1,k1,pre − P n−1,k1,post
)
and the values of Kr, Aref , Kp and kL are
computed for the translaminar portion of the central retinal artery
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– Compute Rn,k1d using formula (2.33)
Rn,k1d =
Krρ
A2ref
[
Pˆ − IOP
KpkL
+ 1
]−4
, (2.39)
where Pˆ =
(
P n−1,k1,post − P n−1,k1,2
)
and the values of Kr, L, Aref , Kp and kL
are computed for the intraocular portion of the central retinal artery
– Compute Rn,k4a and R
n,k
4b using a modified version of formula (2.32) to ac-
count for the architecture from Takahashi et al. [59]
Rn,k4a = R
n,k
4b = 0.5

KrρL
A2ref
[
1− Pˆ − IOP
Kp
]4/3
, if Pˆ − IOP ≤ 0
13∑
i=1
Kr,iρLi
A2ref,i
[
Pˆi − IOP
Kp,ikL,i
+ 1
]−4
, if Pˆ − IOP > 0,
(2.40)
where Pˆ = P n−1,k4 and the values of Kr, L, Aref , Kp and kL are computed
for an equivalent venular compartment obtained by lumping the venular
levels from 1 to 13 [59], while the values of Pˆi, Kr,i, Li, Aref,i, Kp,i and kL,i
are computed for each one of the 13 venular compartments in [59]. This
approach was adopted to eliminate the oscillations present in the system
due the collapsibility of the 13 levels of venules from [59]
– Compute Rn,k5a using formula (2.32)
Rn,k5a =

KrρL
A2ref
[
1− Pˆ − IOP
Kp
]4/3
, if Pˆ − IOP ≤ 0
KrρL
A2ref
[
Pˆ − IOP
KpkL
+ 1
]−4
, if Pˆ − IOP > 0,
(2.41)
where Pˆ =
(
P n−1,k4,5 − P n−1,k5,post
)
and the values of Kr, L, Aref , Kp and kL
are computed for the intraocular portion of the central retinal vein
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– Compute Rn,k5b using a modified version of formula (2.32) that includes the
variation along the coordinate ζ of the value of PLC as shown in Figure 2.9
Υ(ζ) =

Krρ
A2ref
[
1− Pˆ − PLC(ζ)
Kp
]4/3
, if Pˆ − PLC(ζ) ≤ 0
KrρL
A2ref
[
Pˆ − PLC(ζ)
KpkL
+ 1
]−4
, if Pˆ − PLC(ζ) > 0
(2.42)
and
Rn,k5b =
∫ −hLC/2
hLC/2
Υ(ζ) dζ, (2.43)
where Pˆ =
(
P n−1,k5,post − P n−1,k5,pre
)
and the values of Kr, Aref , Kp and kL are
computed for the translaminar portion of the central retinal vein;
• Step 3: Solve the linearized version of system (2.5) for P n,kj , j = 1, 2, 4, 5
C1
d(Pn,k1 − RLTp)
dt
=
Pnin − Pn,k1
Rin +R1a
− P
n,k
1 − Pn,k2
R1b +R
n,k
1c +R
n,k
1d +R2a
C2
d(Pn,k2 − IOP)
dt
=
Pn,k1 − Pn,k2
R1b +R
n,k
1c +R
n,k
1d +R2a
− P
n,k
2 − Pn,k4
R2b +R3a +R3b +R
n,k
4a
C4
d(Pn,k4 − IOP)
dt
=
Pn,k2 − Pn,k4
R2b +R3a +R3b +R
n,k
4a
− P
n,k
4 − Pn,k5
Rn,k4b +R
n,k
5a +R
n,k
5b +R5c
C5
d(Pn,k5 − RLTp)
dt
=
Pn,k4 − Pn,k5
Rn,k4b +R
n,k
5a +R
n,k
5b +R5c
− P
n,k
5 − Pnout
R5d +Rout
;
(2.44)
• Step 4: Compute the value of the retinal blood flow Qn,k and update the
value of the pressures P n,kj j ∈ H using Ohm’s law;
• Step 5: If k ≥ 1 check for the periodicity of the solution of system (2.44)
max
j=1,2,4,5
(
maxn=0,...,N |P n,kj − P n,k−1j |
maxn=0,...,N |P n,kj |
)
< φ, (2.45)
where φ is a given tolerance;
• Step 6: If (2.45) is satisfied, then P n,kj j ∈ H, n = 0, . . . , N is the pressure
solution at the nodes of the system in Figure 2.1 for a complete cardiac cycle.
If (2.45) is not satisfied then set P 0,k+1j = P
N,k
j j ∈ H and return to Step 2.
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2.3 Results
Six different cases corresponding to different clinical conditions are simulated us-
ing the model (2.5). The six cases represent patients with high, normal and low
arterial blood pressure (HBP-, NBP-, LBP-), with functional or absent blood flow
autoregulation (-wAR, -woAR), as summarized in Table 2.8. Systolic/diastolic ar-
terial blood pressures for cases HBP-, NBP- and LBP- are assumed to be 140/90
mmHg, 120/80 mmHg and 100/70 mmHg, respectively. Functional autoregulation is
simulated by allowing arteriolar resistances R2a and R2b to vary according to equa-
tion (2.35). To simulate the absence of autoregulation, arteriolar resistances R2a and
R2b do not change and are set equal to their control values R2a. and R2b.
Table 2.8.
Representative cases for model simulations. The cases represent individu-
als with normal, high and low arterial blood pressure (NBP-, HBP-, LBP-)
and with functional or absent blood flow autoregulation (-wAR, -woAR).
Case Acronym Description
High BP HBP- Systolic/diastolic blood pressure = 140/90 mmHg
Normal BP NBP- Systolic/diastolic blood pressure = 120/80 mmHg
Low BP LBP- Systolic/diastolic blood pressure = 100/70 mmHg
Functional AR -wAR Variable arteriolar resistances, see equation (2.35)
Absent AR -woAR Arteriolar resistances held fixed at control values
2.3.1 Model validation
The model predicted mean values of blood velocity and flow along the retinal
vascular network obtained for the NBPwAR case (which represents a healthy clinical
condition) are compared in Figures 2.10a and 2.10b with measurements obtained by
Garcia et al. [85] and Riva et al. [86] using bidirectional laser Doppler velocimetry
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in healthy individuals. The pressures Pi at each node of the network are computed
from (2.5); the velocity and flow in arterioles, capillaries and venules are determined
from these pressures and the calculated resistances R. The model predicted values of
total retinal blood flow for IOP = 15 mmHg and MAP between 65 and 115 mmHg
are compared with clinical data [49, 55–57] in Figure 2.10c. The model predicted
values are normalized with respect to the control state, and the measured data are
normalized with respect to their reported baseline value.
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Figure 2.10. (a) Comparison of model predicted values (solid line) of blood
velocity with measured data (open triangles [85], black dots [86]) for ves-
sels of various diameter. (b) Comparison of model predicted values (solid
line) of volumetric blood flow with measured data (open triangles [85],
black dots [86]) for vessels of various diameter. (c) Comparison of model
values (solid line) of normalized total retinal blood flow with measured
data (black dots [55], open triangles [57], open squares [57], open dia-
monds [56], plusses [49]) for various mean arterial pressures (MAP). In all
model simulations, IOP = 15 mmHg.
2.3.2 Theoretical investigations
The mathematical model is used to investigate the effects of blood pressure and
blood flow autoregulation on the IOP-induced hemodynamic changes in total retinal
blood flow, CRA blood velocity and intraluminal blood pressure along the retinal
vasculature. The model predictions for total retinal blood flow (computed as the
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time-average of Q(t) over a cardiac cycle), peak systolic velocity (PSV, maximum
value of centerline blood velocity along a cardiac cycle), end diastolic velocity (EDV,
minimum value of centerline blood velocity along a cardiac cycle) and resistive index
(RI = (PSV-EDV)/PSV) in the CRA are compared for cases NBPwAR, NBPwoAR,
HBPwAR, HBPwoAR, LBPwAR and LBPwoAR in Figure 2.11.
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Figure 2.11. Model predicted values of total retinal blood flow; peak
systolic velocity in the central retinal artery (CRA-PSV); end diastolic
velocity in the CRA (CRA-EDV); and resistivity index in the CRA (CRA-
RI) as IOP varies between 15 and 45 mmHg for theoretical patients with
low, normal or high blood pressure (LBP-, NBP-, HBP-) and functional
or absent blood flow autoregulation (-wAR, -woAR).
Figure 2.12 reports the IOP ranges in 15− 30 mmHg for which the values of total
retinal blood flow (Q) and the PSV, EDV and RI in the CRA are within ±3% of their
control values, as predicted by the mathematical model for six theoretical patients. In
the low blood pressure cases (LBPwAR and LBwoAR), the values of Q and EDV are
never within 3% of their control values. The small (3%) change in blood flow is chosen
as a rough threshold for quantifying the regime when autoregulation is successful.
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Figure 2.12. Model predicted ranges of IOP in 15−30 mmHg for which the
values of total retinal blood flow (Q, black), PSV (blue), EDV (red) and
RI (green) are within ±3% of their control state values for six theoretical
patients with low, normal or high blood pressure (LBP-, NBP-, HBP-)
and functional or absent blood flow autoregulation (-wAR, -woAR).
Total retinal blood flow
As shown in Figures 2.11 and 2.12, the model predicted average blood flow over
a cardiac cycle remains relatively constant when IOP= 15− 25 mmHg in NBPwAR
individuals. In the HBPwAR case, relatively constant flow is predicted when IOP=
25 − 30 mmHg. In the remaining cases, the model predicts a slight or nonexistent
autoregulation plateau when IOP= 15− 30 mmHg.
CRA blood velocity
Although a monotone decrease in PSV and EDV with IOP elevation is predicted
in most of the theoretical patients, Figures 2.11b and 2.11c show that the NBPwAR
and HBPwAR cases exhibit a slight PSV increase for IOP within the regulating range,
namely between 15 and 25 mmHg for NBPwAR and between 25 and 30 mmHg for
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HBPwAR. For all six cases, the model predicts an increase in the CRA resistivity
index with IOP, as shown in Figures 2.11d and 2.11h. As shown in Figure 2.12, for
all the cases except HBP-, the range of IOP for which PSV is within 3% of its control
values is larger than the range for EDV. In the HBPwAR, case the PSV value is
greater than 3% of its baseline value for all of the simulated values of IOP.
Intraluminal blood pressure
The model predicted values of blood pressure in the five model compartments
of the retinal vasculature for IOP equal to 15, 30 and 45 mmHg are compared in
Figure 2.13 for the six representative clinical cases described in Table 2.8. Pronounced
changes in pressure are visible in the CRA, arterioles, capillaries and venules with IOP
elevation, while the pressure in the CRV remains relatively constant. As expected,
when IOP is sufficiently high, the venules collapse. The degree to which the vessels
collapse depends on the MAP of the individual. In particular, the model predicts
that for an IOP = 45 mmHg, the venules collapse to a lesser extent in HBP- patients
than in NBP- and LBP- patients.
2.3.3 Comparison between model predictions and clinical data
The mathematical model is used to interpret clinically measured hemodynamic
responses to surgical IOP reduction in glaucoma patients and induced IOP elevation
in healthy individuals.
Surgical IOP reduction on glaucoma patients
Galassi et al. [10] and Trible et al. [15] report an increase in CRA blood velocity
and a decrease in RI following trabeculectomy (group (a) in Galassi et al. and Trible
et al.) and deep sclerectomy (group (b) in Galassi et al.), as indicated by the changes
(∆) in mean flow velocity (MFV), PSV, EDV and RI summarized in Table 2.9. Since
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Figure 2.13. Model predicted values of blood pressure in CRA (P1),
arterioles (P2), capillaries (P3), venules (P4), and CRV (P5) for IOP =
15, 30, and 45 mmHg for six theoretical patients with high (blue), nor-
mal (black) and low (green) blood pressure (HBP-, NBP-, LBP-), and
functional (solid) or absent (dashed) blood flow autoregulation (-wAR,
-woAR).
the study by Trible et al. [15] reports MAP values of 107 ± 14.7 mmHg, we use
HBP-model predictions that correspond to MAP = 106.7 mmHg as a comparison
with this set of clinical data. Also, to be consistent with the data, model simulations
assume that IOP = 30 mmHg before surgery and IOP = 15 mmHg after surgery.
The model assumptions have been indicated with shaded boxes in Table 2.9. Model
predicted values of ∆MFV, ∆PSV, ∆EDV and ∆RI for the HBPwoAR case and
the trabeculectomy data reported by Trible et al. [15] differ only by 0.35 cm/s, 0.54
cm/s, 0.56 cm/s and 0.02, respectively. The model predicted values of ∆EDV and
∆RI for the HBPwAR and HBPwoAR cases and the deep sclerectomy data reported
by Galassi et al. [10] (group (b)) also show the same qualitative trends.
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Table 2.9.
Changes in peak systolic velocity (PSV), end diastolic velocity (EDV),
resistivity index (RI) and mean flow velocity (MFV) in the central retinal
artery as IOP is reduced by trabeculectomy (group (a) in Galassi et al. [10]
and Trible et al. [15] ), deep sclerectomy (group (b) in Galassi et al. [10])
and model simulations. Model assumptions are reported in shaded boxes.
Parameter Clinical Studies Mathematical Model
Study [10] Group (a) [10] Group (b) [15] HBPwAR HBPwoAR
Pre-op IOP, mmHg 25.27± 6.24 24.05± 4.27 27.5± 8.8 30 30
Post-op IOP, mmHg 9.86± 2.10 10.79± 2.27 12.5± 10.5 15 15
Post-op MAP, mmHg − − 107± 14.7 106.7 106.7
Post-op MAP, mmHg − − 102.2± 11.5 106.7 106.7
∆MFV, cm/s − − 1.4 1.05 1.75
∆PSV, cm/s − − 1.2 0.15 1.73
∆EDV, cm/s 0.40 0.47 0.96 1.32 1.52
∆RI −0.06 −0.05 −0.12 −0.11 −0.10
Model assumptions are reported in boldface. Dashes indicate that the quantity was not
reported in the article.
Induced IOP elevation on healthy individuals
The model predicted values of PSV and EDV in the CRA for IOP between 15
and 45 mmHg are compared with clinical data [11] in Figure 2.14a. In the study by
Harris et al. [11], PSV and EDV measurements were performed at approximately 3
mm behind the optic disc surface, corresponding to the retrobulbar CRA segment
in our model. Since the study involved healthy individuals, the clinical data are
compared with the NBP-model predictions. Figure 2.14a shows that the PSV values
measured by Harris et al. and predicted by our model in the NBP- case fall precisely
in the same range.
The model-predicted values of the percent change in the CRA mean flow velocity
with IOP elevation are compared with the clinical data by Findl et al. [9] in Fig-
41
ure 2.14b. In the study by Findl et al., IOP was raised 20 mmHg above baseline
in two steps and then was reduced by 10 mmHg before releasing the suction cup.
Measurements were performed at approximately 3 mm behind the optic disc surface,
corresponding to the retrobulbar CRA segment in our model. Findl et al. considered
healthy individuals and therefore the clinical data are compared with the NBP- model
predictions.
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Figure 2.14. (a) Comparison between peak systolic velocity (PSV) and
end diastolic velocity (EDV) measured by Harris et al. [11] in the central
retinal artery (CRA) and the model predicted values in the NBPwAR and
NBPwoAR cases. (b) Comparison between the percent change in CRA
mean flow velocity measured by Findl et al. [9] and the model predicted
values in the NBPwAR and NBPwoAR cases.
2.3.4 Trabeculectomy simulations
Alterations in retinal hemodynamics following trabeculectomy (TB) have been
reported by several clinical studies [10,14,15], although no changes in blood velocity in
the CRA where observed after trabeculectomy in other studies [18,25]. This suggests
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that individual factors might mediate the hemodynamic outcomes of the procedure,
including arterial blood pressure and autoregulation [37,87].
The model results are compared with the clinical data collected in a study involv-
ing 30 patients (age 62.7 ± 9.7) who underwent trabeculectomy [88]. In this study,
IOP and PSV and EDV in the CRA were measured before and after trabeculec-
tomy in both the healthy eye and the eye on which surgery was performed. Arterial
blood pressure was also measured before and after trabeculectomy and did not show
significant changes.
Table 2.10.
Representative cases for trabeculectomy model simulations. The cases
represent individuals with normal and high blood pressure (NT-, HT-)
and with functional or absent blood flow autoregulation (-wAR, -woAR).
The values of pressure considered in the case HT are the same average
values reported in [88].
Case Acronym Description
High BP HT- Systolic/diastolic blood pressure = 143/84 mmHg
Normal BP NT- Systolic/diastolic blood pressure = 120/80 mmHg
Functional AR -wAR Variable arteriolar resistances, see equation (2.35)
Absent AR -woAR Arteriolar resistances held fixed at control values
The values of PSV, EDV, Q in the CRA are computed with the mathematical
model for (i) IOP= 28.7 mmHg and 13.1 mmHg, corresponding to IOP levels before
and after trabeculectomy; (ii) systolic and diastolic blood pressures SP/DP= 120/80
mmHg and 143/84 mmHg, representing normotensive (NT-) and hypertensive (HT-)
subjects; and functional autoregulation (-wAR) or absent autoregulation (-woAR),
as reported in Table 2.10.
Statistical analysis of the clinical data shows that PSV and EDV increase from
7.81± 2.51 cm/s and 2.39± 0.94 cm/s to 8.90± 2.66 cm/s and 2.77± 1.14 after TB,
as IOP decreases from 28.7±7.9 mmHg to 13.1±5.8 mmHg (reported in Table 2.11).
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The mean values of SP/DP in [88] are 143/84 mmHg, as for the HT case of the
mathematical model.
Table 2.11.
Changes in IOP and CRA hemodynamics following trabeculectomy [88].
Pre-Trabeculectomy Post-Trabeculectomy
Parameter Healthy Eye Operated Eye Healthy Eye Operated Eye
IOP, mmHg 17.9± 5.7 28.7± 7.9 16.4± 5.2* 13.1± 5.8*
PSV, cm/s 8.73± 1.49 7.81± 2.51 8.59± 2.28 8.90± 2.66*
EDV, cm/s 2.89± 1.28 2.39± 0.94 2.75± 1.04 2.77± 1.14*
*Paired Samples t test. Significance level p< 0.05.
Additional information on the velocity variations in each patient after trabeculec-
tomy is provided in the scatter plots reported in Figure 2.15, where changes in PSV
and EDV are reported as a function of MAP for each patient. While the majority
of patients showed an increase in PSV and EDV after trabeculectomy, in agreement
with the trend of the average values in Table 2.11, some patients showed a decrease
in either PSV or EDV following trabeculectomy.
The model predictions for PSV and EDV values in the CRA over a cardiac cycle
before and after trabeculectomy are displayed in Figure 2.16. The model predicts
an increment in both PSV and EDV for the cases HTwAR, HTwoAR and NTwoAR
as IOP is reduced from 28.7 mmHg to 13.1 mmHg. However, for the case NTwAR,
the model predicts an increase of EDV and a decrease of PSV values. In particular,
Figure 2.16c shows that for almost half of the cardiac cycle the velocity profile before
TB is below the value predicted after TB since the difference between the values
before and after TB is negative.
In Figure 2.17, clinical observations are simulated using the model by calculating
the mean volumetric retinal blood flow over a cardiac cycle. The mean blood flow
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(a)
PSV post-TB − PSV pre-TB
(b)
EDV post-TB − EDV pre-TB
Figure 2.15. Scatter plot of the velocity difference in the CRA for the
patients in [88]. PSV (a) and EDV (b).
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increases as IOP is decreased following trabeculectomy in the HTwoAR and NTwoAR
cases, but remains almost constant in the NTwAR case. The HTwAR case shows an
intermediate trend. The dotted line in Figure 2.17 represents the IOP value at which
we have the intersection between the average retinal blood flow values for the cases
NTwAR and NTwoAR.
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Figure 2.17. Model predictions of average retinal blood flow in a cardiac
cycle for the four theoretical patients.
2.4 Discussion
The combination of multiple factors, including IOP, BP and autoregulation, plays
a primary role in determining retinal and retrobulbar hemodynamics. It is widely
recognized that IOP elevation poses a serious challenge to tissue perfusion, and sev-
eral animal and human studies, in addition to the results of the theoretical model
presented here, have suggested that arterial blood pressure [3,37–41], and blood flow
autoregulation [3,42–44], are also important factors influencing blood flow. However,
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the difficulty of isolating and assessing the contributions of arterial blood pressure
and blood flow autoregulation in vivo limits the current understanding of their effects
on tissue perfusion as IOP varies [37]. This work introduces a mathematical model
that can isolate and assess the contributions of arterial blood pressure, blood flow
autoregulation and IOP to retinal hemodynamics.
2.4.1 Model validation
Every mathematical model is based on simplifying assumptions whose validity
needs to be verified by comparing model predictions with data from independent
experimental and clinical studies. Figure 2.10 shows that the model predicted values
of velocity and flow are consistent with clinical measurements [49,55–57,85,86]. These
measurements were used for comparison purposes only and were not used to estimate
any of the model parameters listed in Tables 2.1, 2.2, 2.4, 2.5, 2.6, and 2.7. It
is important to note that many of the model parameters vary among individuals.
For example, blood pressure and elasticity of the vessel walls differ depending on
age [89–92], ethnicity [93, 94] and disease [95, 96]; many studies have shown that
the geometric and mechanical properties of the lamina cribrosa and sclera undergo
changes with age [97, 98], ethnicity [75, 99], and disease [100, 101], and these changes
strongly affect the biomechanical response of the optic nerve head tissues to IOP
alterations [102–108]. The clinical studies [49,55–57,85,86] used for model comparison
did not report the parameter values for the geometric and mechanical properties of
the lamina cribrosa and sclera, and therefore the model simulations were performed
using the literature-based parameter choices reported in Tables 2.6 and 2.7. Future
data on the geometric and structural properties of the retinal vessels collected from
populations including a wide age range will help improve upon the current model
predictions.
Despite the simplified vascular architecture and the literature-based parameter
choices, the model predictions of velocity and flow reported in Figure 2.10 are con-
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sistent with six independent clinical studies, providing evidence that our modeling
choices are appropriate and physiologically reasonable.
2.4.2 Theoretical investigations
The model simulations suggest that the hemodynamic response of the retinal
vasculature to IOP variations differs noticeably among individuals with different blood
pressure and functionality of autoregulation.
Total retinal blood flow
The model predicts that the autoregulation plateau would shift towards higher
IOP values as MAP increases, as shown in Figure 2.12. This is in agreement with
the study by He et al. [39], who induced IOP elevations on Long-Evan rats with low,
moderate, and high MAP levels and found that a higher IOP was needed to attenuate
ocular blood flow in animals with higher MAP. The shift in the autoregulation plateau
was also predicted by the theoretical work of Arciero et al. [45], whose microcirculation
model suggested that autoregulation fails to operate over its expected range of arterial
pressure if IOP is increased.
CRA blood velocity
The model predicts that the blood flow velocity in the CRA does not always
decrease with IOP elevation. Figures 2.11b and 2.11c show a slight increase in PSV
in the range of IOP values for which autoregulation is achieved, namely between 15
and 25 mmHg for NBPwAR and between 25 and 30 mmHg for HBPwAR.
These findings have important clinical implications. For example, the model sug-
gests that a 10 mmHg IOP reduction in an individual with normal blood pressure and
functional autoregulation (NBPwAR) would result in a noticeable increase in PSV and
EDV in the CRA blood velocity and a noticeable increase in total retinal blood flow if
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IOP is reduced from 40 to 30 mmHg. However, only minimal hemodynamic changes
are predicted if IOP is reduced from 25 to 15 mmHg. These findings could help to
explain why some studies [10, 14, 15] report significant hemodynamic changes follow-
ing trabeculectomy, while others do not [18, 25]. The model also suggests that IOP
reductions of approximately 5 mmHg would result in minor hemodynamic changes
in all of the cases considered here, which is consistent with clinical data related to
topical medications [8,12,13,16,17,20–24,26–28]. However, reductions in IOP greater
than 5 mmHg may have a more significant effect on retinal hemodynamics.
Intraluminal blood pressure
Intraluminal blood pressure is the main driving force of local tissue perfusion and
can be measured in retinal vessels by artificially increasing IOP using ophthalmody-
namometry [109–112]. However, the level of IOP may have an important impact on
the intraluminal pressure in retinal vessels, which is uncovered by the mathematical
model. The model predicts that increased IOP induces a significant increase in the
intraluminal blood pressure in all vascular compartments upstream of the CRV. This
finding is consistent with the experimental observations by Gluksberg and Dunn [113]
and Attariwala et al. [114] on live anesthetized cats. A hydraulic feedback mechanism
could explain this phenomenon [113, 114]. Veins are more susceptible than arteries
to IOP elevation, since veins have thinner walls and lower intraluminal pressure than
arteries and, under extreme conditions, act like a Starling resistor and collapse. Thus,
as IOP increases, resistance to flow increases in veins more than in arteries, leading
to an overall increase in intraluminal pressure upstream of the veins [115, 116]. In
addition, the model predicts that IOP elevation would affect intraluminal arterial
pressure differently depending on whether blood flow autoregulation is functional or
absent. The study by Jonas [110] supports this finding, since correlation coefficients
between intraluminal blood pressure measured via ophthalmodynamometry and sys-
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temic blood pressure were found to be lower in eyes with retinal or orbital diseases
than in the control group.
2.4.3 Comparison between model predictions and clinical data
A good qualitative and quantitative agreement in the hemodynamic response to
IOP changes was found between clinical data and model predictions. This suggests
that the mathematical model could be used to anticipate the hemodynamic outcome
of clinical IOP modulation on specific patients.
Surgical IOP reduction on glaucoma patients
The clinical studies by Galassi et al. [10] and Trible et al. [15] suggest that clin-
ically measurable changes in the retinal hemodynamic parameters occur in patients
with elevated blood pressure as IOP is reduced from 30 to 15 mmHg. The theoret-
ical analysis in the current study suggests that these changes are less pronounced
in HBPwAR patients than in HBPwoAR patients, likely due to the compensatory
mechanisms of autoregulation [117]. However, the model also suggests that if a 15
mmHg IOP reduction falls within the regulating range predicted for HBP-patients,
the consequent hemodynamic changes would be negligible. This might explain why
the trabeculectomy study by Cantor [18] did not observe any significant change in
ocular blood flow parameters despite significant IOP reduction.
Induced IOP elevation on healthy individuals
The ability to autoregulate blood flow has a noticeable effect in individuals with
normal blood pressure experiencing induced IOP elevation. Figure 2.14a shows good
agreement between clinical data and model predictions in the NBPwoAR case when
IOP is increased. Blood velocity measurements were performed immediately after
IOP elevation (i.e., before autoregulation took effect), explaining why the NBPwoAR
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model predictions match the data more closely than the NBPwAR predictions. Con-
sistent with this interpretation, there is better agreement between the data and the
NBPwAR case in Figure 2.14b since the blood velocity measurements were performed
at least 5 minutes after IOP elevation, leaving time for autoregulation to exert its
influence.
2.4.4 Trabeculectomy simulations
The clinical data from Table 2.11 show that, on average, trabeculectomy leads
to an increase in both PSV and EDV as IOP is reduced. However, Figure 2.15
shows a more complicated scenario in which both increases and decreases in PSV and
EDV are possible outcomes of trabeculectomy depending on the patient. The model
predictions show how the hemodynamic outcomes following trabeculectomy can vary
among patients depending on blood pressure and autoregulatory capacity.
For a normotensive patient, the same IOP reduction following trabeculectomy
can cause opposite variations in PSV and EDV depending on the status of the au-
toregulatory mechanisms, as shown in Figure 2.16. For a hypertensive patient the
autoregulatory mechanism starts working at a higher level of IOP, which means that
when IOP is reduced, the system falls outside of the autoregulatory range. This ex-
plains why the change in velocity in the HTwAR case is qualitatively similar to the
NTwAR case but quantitatively different in Figure 2.16c.
The level of blood pressure and the functionality of AR also influence the model
predictions of the retinal blood flow value over a cardiac cycle. When autoregula-
tion is within its working range (NTwAR), flow remains almost constant as IOP is
reduced following trabeculectomy. This is due to the fact that the level of blood flow
before trabeculectomy was close to the baseline (healthy). In the hypertensive case
the autoregulation is working properly only when IOP=28.7 mmHg, and the model
predicts a value of blood flow that is higher in the HTwAR than in the HTwoAR.
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On the other hand when IOP decreases, the model predicts an increase in blood flow
over the baseline (healthy) value for both the HTwAR and HTwoAR cases.
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3. COUPLED MODEL FOR VASCULAR REGULATION IN
THE RETINA
The retina exhibits vascular regulation (VR) of blood flow in response to changes in
perfusion pressure and the metabolic needs of the tissue. Autoregulation (AR) is the
ability to maintain relatively constant level of blood flow despite changes in perfusion
pressure, whereas metabolic regulation (MR) is the ability to alter the level of blood
flow in response to changes in tissue oxygen demand. AR and MR are achieved by
varying the vascular tone of arterioles smooth muscles, causing the vessels to constrict
or dilate.
The model presented in Chapter 2 describes VR using a formula which phenomeno-
logically regulates the level of blood flow in the retina. In this Chapter we improve
this phenomenological approach by coupling the model described in Chapter 2 with
a vessel wall mechanics model of blood flow VR in the retinal microcirculation [45].
This mechanistic model describes the response of vessels to local changes in pressure,
shear stress, carbon dioxide and to the downstream metabolic state communicated
via conducted responses.
Although both models separately provide insight into key aspects of retinal blood
flow regulation, the macrocirculation model is limited by using a phenomenological
description of autoregulation, and the microcirculation model is limited by describing
only the dynamics in the retinal microcirculation. In this Chapter, the microcircu-
lation and macrocirculation models are combined into a single coupled model that
includes a mechanistic description of blood flow VR in the microcirculation as well
as the effects of IOP on the CRA and CRV.
In Section 3.1 we describe the governing equations of the coupled model. In
Section 3.2 we illustrate the solution algorithm for the coupled model. In Section 3.3
we present the model predictions of pressure, retinal blood flow and oxygen saturation
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in response to changes in systemic blood pressure, intraocular pressure and tissue
oxygen demand. In Section 3.4 we discuss the model results and limitations. The
material and results presented in this Chapter are partially published in [118,119]
3.1 Methods
3.1.1 Governing equations
Retinal circulation is simulated using a mathematical model that describes the
hemodynamic and mechanical properties of multiple vessel compartments, as depicted
in Figure 3.1. As described in Chapter 2, the model is analogous to an electrical circuit
in which blood is propelled through the system by a pressure gradient and the vessels
are modeled as a network of resistors, representing the resistances to blood flow offered
by the system. The model developed in this Chapter does not include capacitors since
it focuses only on the steady state solution instead of on time-dependent dynamics.
An analogy to Ohm’s Law is used to describe the blood flow (Q) through the system:
Q = ∆P/R, where ∆P represents the pressure difference along a vessel and R is the
vascular resistance. The model developed here is obtained by coupling two previously
developed mathematical models for the retinal circulation.
The first model, described in [45] (herein referred to as themicrocirculation model),
describes the blood flow through the large arterioles (LA), small arterioles (SA),
capillaries (C), small venules (SV), and large venules (LV). Diameters of the LA
and SA depend on the passive and active length-tension characteristic of the vessel
wall. The active tension is generated by activation of the vascular smooth muscle
according to changes in pressure, shear stress, oxygen (O2) metabolism and carbon
dioxide (CO2). Thus, the microcirculation model provides a mechanistic description
of retinal vascular regulation.
The second model, described in Chapter 2 (herein referred to as the macrocircula-
tion model), simulates blood flow upstream, within, and downstream of the microcir-
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Figure 3.1. Schematic for retinal vascular network in the coupled model.
The vasculature is divided into seven compartments: the central retinal
artery (CRA), largearterioles (LA), small arterioles (SA), capillaries (C),
small venules (SV), large venules (LV), and central retinal vein (CRV).
Each compartment is modeled as a resistor (R). The retinal vasculature
encompasses three regions: the intraocular region, translaminar region,
and retrobulbar region. Thevessels in the intraocular region areexposed
to intraocular pressure (IOP), the vessels in the translaminar region are
exposed to an external pressure that depends on the stress in the lam-
ina cribrosa (shaded gray), and the vessels in the retrobulbar region are
exposed to the retrolaminar tissue pressure (RLTp). Resistors marked
with arrows indicate that their diameters changeeither passively (due to
IOP) or actively (due to vascular regulation). Dashed circled regions in-
dicatethetwo previousmodels (themacrocirculation model, presented in
Chapter 2, and themicrocirculation model [45]) that arecombined in the
current work to form thecoupled model.
Figure 3.1. Schematic for retinal vascular network in the coupled model.
The vasculature is divided into seven compartments: the central retinal
artery (CRA), large arterioles (LA), small arterioles (SA), capillaries (C),
small venules (SV), large venules (LV), and central retinal vein (CRV).
Each compartment is modeled as a resistor (R). The retinal vasculature
encompasses three regions: the intraocular region, translaminar region,
and retrobulbar region. The vessels in the intraocular region are exposed
to intraocular p essure (IOP), the vessels in the translaminar region are
exposed to an external pressure that depends on the stress in the lam-
ina cribrosa (shaded gray), and the vessels in the retrobulbar region are
exposed to the retrolaminar tissue pressure (RLTp). Resistors marked
with arrows indicate that their diameters change either passively (due to
IOP) or actively (due to vascular regulation). Dashed circled regions in-
dicate the two previous models (the macrocircula ion model, presented in
Ch pter 2, a d the microcirculation model [45]) that are combined in the
current work to form the coupled model.
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culation. In particular, the macrocirculation model implements mechanical principles
to describe blood flow through the CRA and the CRV.
Coupling the models substitutes the phenomenological approach described in Sec-
tion 2.1.6 with the mechanistic one used in [45], providing a more accurate description
of retinal regulation in the context of a retinal vascular model that includes the hemo-
dynamics in the vessels that supply (CRA) and drain (CRV) the retina. A complete
description of the two original (i.e., uncoupled) models can be found in [45] (micro-
circulation model), and in Chapter 2 (macrocirculation model). In this Section, the
relevant features of and changes to these two models necessary to generate the coupled
model will be discussed.
As in the previous two models, the coupled model is characterized by both variable
and fixed resistances. The resistances Rin and Rout describe the blood vessel resistance
upstream of the CRA and downstream of the CRV. Variable resistances are marked
with an arrow in Figure 3.1, and the remaining resistances are fixed. Resistances R2a
and R2b are vasoactive resistances that change according to VR mechanisms in the
system. Resistances R1,LC , R1,IOP , R5,IOP and R5,LC are passive resistances that
change according to the Law of Laplace (see Section 2.1.5) due to the external pres-
sure of the IOP in the intraocular region and the mechanical stress exerted by the
lamina cribrosa on the CRA and the CRV in the translaminar region (see Figure 3.1).
The action of the lamina cribrosa on the translaminar portion of the CRA and CRV
is described in Section 2.1.4 and in [48]. The coupled model differs from the macro-
circulation model in the modeling assumption regarding the passive resistances: (i)
the resistances R1,LC , R1,IOP , R5,IOP and R5,LC are modeled as compliant (not col-
lapsible) tubes and the Starling effect is not included (see Section 2.1.5 for reference);
(ii) venular resistances R4a and R4b are assumed to be constant.
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Conservation of flow in the network yields the following nonlinear system of alge-
braic equations:
Pin − P1,post
Rin +R1 +R1,LC(P )
− P1,post − P1,2
R1,IOP (P )
= 0
P1,post − P1,2
R1,IOP (P )
− P1,2 − P4,5
R2a(P ,D,A) +R2b(P ,D,A) +R3 +R4a +R4b
= 0
P1,2 − P4,5
R2a(P ,D,A) +R2b(P ,D,A) +R3 +R4a +R4b
− P4,5 − P5,post
R5,IOP (P )
= 0
P4,5 − P5,post
R5,IOP (P )
− P5,post − Pout
R1,LC(P ) +R5 +Rout
= 0,
(3.1)
where the definitions of the pressures (P ) and resistances (R) are shown in Figure 3.1.
The four variables of the system are given in the vector
P =
[
P1,post, P1,2, P4,5, P5,post
]
. (3.2)
Pin and Pout are given data; the value of Pout is fixed at 14 mmHg, while the value of Pin
is varied in the different simulations. Some of the vascular resistances depend on the
pressure values (indicated in equation (3.1) by an explicit dependence in parentheses),
while the remaining resistances are constant and equal to their control state values
listed in Table 3.1. R2a and R2b also depend on the diameter (D) and smooth muscle
activation (A) values obtained from system (3.3).
3.1.2 Modeling of vascular regulation
Active changes in LA and SA resistances (R2a and R2b) are achieved via four
regulatory mechanisms that respond to changes in (a) systemic pressure (myogenic
response), (b) wall shear stress (shear stress response), (c) adenosine triphosphate
(ATP) concentration (metabolic response) and (d) carbon dioxide concentration (car-
bon dioxide response).
57
Table 3.1.
Computed values of the vascular resistances at the control state.
Resistance
Value,
Resistance
Value,
mmHg·s/mL mmHg·s/mL
Rin 2.68 · 104 R4a 3.03 · 103
R1 8.60 · 103 R4b 1.86 · 103
R1,LC 1.97 · 102 R5,IOP 3.24 · 102
R1,IOP 1.01 · 103 R5,LC 6.09 · 101
R2a 8.21 · 103 R5 2.70 · 103
R2b 1.32 · 104 Rout 6.80 · 103
R3 6.63 · 103
The following equations are solved for the steady state diameter and smooth
muscle activation of the LA and SA according to these four VR mechanisms:
dDi
dt
=
1
ϕd
Di
T i
(
Ti − Ttotal,i
)
,
i = LA,SA,
dAi
dt
=
1
ϕa
(
Atotal,i − Ai
)
,
(3.3)
where Di and Ai are the diameter and level of smooth muscle activation, respectively.
Constants ϕd = 1 s and ϕa = 1 min are the characteristic time constants regulating
the changes in diameter and smooth muscle activation, and Di and T i are the control
state values for diameter and wall tension. The wall tension Ti is given by the Law
of Laplace as
Ti =
Pi − IOP
2
Di, i = LA,SA, (3.4)
where Pi is the intraluminal pressure of the i-th compartment. The model represen-
tation for vessel wall tension
Ttotal,i = Tpass,i + Atotal,iTactive,i (3.5)
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is the sum of a passive component (Tpass) that arises from the structural elements of
the vessel and a maximally active component (Tactive) that arises from the constriction
or relaxation of vascular smooth muscles. The passive component is assumed to be
an exponential function of diameter [45]
Tpass,i = Cpass,i e
C′pass,i[(Di/D0,i)−1], (3.6)
and the maximally active component is modeled as a Gaussian function of vessel
diameter [45]
Tactive,i = Cact,i e
−
[
((Di/D0,i)−C′act,i)/C′′act,i
]2
. (3.7)
The value of the constants Cpass, C ′pass, Cact, C ′act, C ′′act, and D0, are taken directly
from [45] and reported in Table 3.2. As defined in [45] the active component of tension
in the vessel wall is the product of the maximally active and Atotal, which is a sigmoidal
function (3.8) that varies between 0 and 1 and depends on a stimulus function (Stone,
(3.9)) that determines the degree of vascular smooth muscles constriction:
Atotal,i =
1
1 + e−Stone,i
, i = LA,SA (3.8)
Stone,i = Cmyo,iTi−Cshear,iτi−Cmeta,iSCR,i−CCO2,iSCO2,i+C ′′tone,i i = LA,SA. (3.9)
The value of the constants Cmyo, Cshear, Cmeta, and CCO2 are obtained from [45] and
reported in Table 3.2. The constant C ′′tone is computed to guarantee that A = 0.5
in the control state. The stimulus function is a linear combination of the myogenic,
shear-dependent, metabolic, and carbon dioxide VR mechanisms.
• The myogenic mechanism contribution is Cmyo,iTi where Ti represents the ten-
sion in the vessel wall computed as in equation (3.4).
• The shear-dependent mechanism contribution is Cshear,iτi where τi is the wall
shear stress
τi =
32µiQc,i
piD3i
, (3.10)
where µi represents the blood viscosity and Qc,i represents the blood flow in an
individual vessel in compartment i.
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Table 3.2.
Values of the constant parameters for vascular regulation mechanisms.
LA SA
Parameter Value Source
Cpass, dyn/cm 361.48 197.01 [45]
C ′pass 53.69 17.60 [45]
Cact, dyn/cm 2114.2 3089.6 [45]
C ′act 0.93 1.02 [45]
C ′′act 0.11 0.20 [45]
Cmyo, cm/dyn 9.2 · 10−3 2.5 · 10−2 [45]
Cshear, cm2/dyn 2.58 · 10−2 2.58 · 10−2 [45]
Cmeta, (µM cm)−1 200 200 [45]
CCO2 , mmHg−1 8 · 10−4 1.31 · 10−4 [45]
C ′′tone 133.16*, 157.43** 60.18*, 70.54**
D0, µm 135.59 73.9 [45]
* Values used for the results presented in Section 3.3.1 and in Section 3.3.2.
** Values used for the results presented in Section 3.3.3.
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• The metabolic mechanism contribution is Cmeta,iSCR,i where SCR is a signal
obtained by the integral of the ATP concentration cATP (s) in plasma [45]. The
ATP release depends on the oxygen saturation, SO2 of blood.
vessel
diameter, Di
tissue
thickness, d
tissue
vessel
s
ζ
Figure 3.2. Krogh cylinder model schematic representation. Oxygen is
assumed to diffuse from a vessel to a surrounding tissue cylinder of thickness
d (left panel). A cross-sectional view of a group of adjacent parallel vessels
is depicted on the right panel.
• The carbon dioxide mechanism contribution is CCO2,iSCO2,i where SCO2 repre-
sents the carbon dioxide signal. This signal is a nonlinear function of the level
of tissue CO2 content (cCO2) and the blood flow in the retinal circulation. More
details on this mechanism can be found in [45].
Once the vessel diameter (D) is determined for the vessels in the LA and SA
compartments, the values of the resistances are computed using Poiseuille’s Law
R =
128µL
pinD4
, (3.11)
where L is vessel length, µ is blood viscosity, and n is the number of vessels in the
compartment.
In this model the transport of oxygen in the retinal vasculature and tissue is
described using a Krogh cylinder type model. Oxygen is assumed to diffuse from a
vessel to a surrounding cylinder of tissue, as in [45] (Figure 3.2).
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3.1.3 Control state
A control state represents conditions in a healthy eye. Control state values are
indicated by an overbar.
As in Section 2.1.2, the control state value of IOP is 15 mmHg, and the control
state value of RLTp is 7 mmHg. The control state values of P in = 62.2 mmHg and
P out = 14 mmHg are determined in the coupled model according to color Doppler
imaging data (Section 2.1.2).
To compute the control state value of Rin and Rout, the control state for the
microcirculation model is computed first as in [45], using the value of P 1,2 and P 4,5
from Chapter 2, Table 2.4. Then, the pressure drop between the nodes P1,2 and P1,in
and between the nodes P4,5 and P5,out is computed using Ohm’s Law. The value of
Rin and Rout is equal to Rin = (P in − P 1,in)/Qun and Rout = (P 5,out − P 4,5)/Qun,
where all the quantities are equal to their control state value and Qun is the value of
blood flow in the control state of the microcirculation model.
The procedure used to compute the control state is iterative and is based on the
control state assumptions described in Chapter 2 and [45]. First, the pressure values
for P1,2 and P4,5 in Table 2.4 provide an initial guess for these pressure values, and
then pressure drops across LA, SA, C, SV, and LV are computed as in [45]. The
control state values of the LA and SA diameters are obtained by solving system (3.3),
assuming that ALA = ASA = 0.5 in the control state. The control state value of the
capillary diameter is assumed to be 6µm, and a symmetry condition that dictates the
length and number of vessels in each compartment is used to determine the control
state diameter values of the SV and LV assuming that the wall shear stress values
at control state are those reported in Table 3.3 [45]. The flow in each compartment
is computed using Poiseuille’s Law, and then the numbers and lengths of the vessels
in each compartment are computed [45]. A comprehensive list of the geometric and
mechanical parameters characterizing the CRA and CRV are given in Chapter 2 and
Table 3.3.
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Table 3.3.
Control state values for retinal vascular network compartments.
Parameter CRA LA SA C SV LV CRV
Diameter D, µm
Retrobulbar 175 − − − − − 238
Translaminar 174.73 − − − − − 238.76
Retrobulbar 173.64 105.54 48.07 6 69.66 155.70 235.18
Length L, mm, total 10 5.86 4.27 0.54 4.27 5.86 10
Retrobulbar 8.8 − − − − − 8.8
Translaminar 0.2 − − − − − 0.2
Retrobulbar 10 5.86 4.27 0.54 4.27 5.86 10
Number of segments n 1 4 38 191172 38 4 1
Wall thickness h, µm 39.72 − − − − − 10.72
Pressure drop ∆P , mmHg 5.96 4.99 7.99 4.02 1.84 1.13 1.88
Shear Stress τ , dyn/cm2
Retrobulbar 36.64 − − − − − 14.87
Translaminar 34.80 − − − − − 14.73
Retrobulbar 35.46 30 30 15 10 10 15.41
Velocity v, cm/s
Retrobulbar 2.53 − − − − − 1.37
Translaminar 2.53 − − − − − 1.36
Retrobulbar 2.57 1.74 0.88 0.01 0.42 0.80 1.40
Once the vascular network geometry for the model is determined, the control
state resistance for each compartment is computed using Poiseuille’s Law (3.11).
System (3.1) is then solved to compute the control state for the coupled model. The
values of P1,2 and P4,5 for the coupled model are compared with the initial guess. The
iterations cease when the difference between the initial guess and the computed value
is within a certain tolerance. If the condition on the tolerance is not satisfied, the
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predicted value is set as the new initial guess and the process is repeated. All control
state values and parameters for the coupled model are listed in Tables 3.1, 3.3, 3.4.
Table 3.4.
Computed values of intraluminal blood pressures at the control state.
Pressure
Value,
Pressure
Value,
mmHg mmHg
P in 62.22 P 3,4 22.97
P 1,in 45.94 P 4a 21.14
P 1,pre 40.71 P 4,5 20.01
P 1,post 40.60 P 5,post 19.81
P 1,2 39.98 P 5,pre 19.78
P 2a 34.99 P 5,out 18.13
P 2,3 27.00 P out 14.00
3.2 Solution algorithm
In this Section we illustrate the solution procedure for coupling the macrocir-
culation and microcirculation models (i.e. coupling the nonlinear problems in sys-
tems (3.1) and (3.3)). The problem is solved with the following fixed point algorithm:
Let the values of IOP, RLTp, SP, DP be given, and let us set an initial guess for
(i) the pressure at the nodes of the system in Figure 3.1, P 0, (ii) the diameter and the
level of smooth muscle activation of the vessels in compartments LA and SA, D0LA,
D0SA, A0LA and A0SA, (iii) the value of oxygen saturation, ATP concentration and CO2
content at the inlet of the CRA, SO2,CRA(0), cATP,CRA(0), cCO2,CRA(0), and (iv) the
value of retinal blood flow Q0.
Let n = 0, . . . , N represent the iterations between the two systems and let us
proceed as follows:
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• Step 1:
– Update Pin to be consistent with the given values of SP and DP
– Solve the lamina cribrosa problem in [48] to obtain the value of PLC(ζ),
with ζ ∈
[
−hLC
2
,
hLC
2
]
For n ≥ 0
• Step 2:
– Compute SnO2,CRA(LCRA), c
n
ATP,CRA(LCRA), cnCO2,CRA(LCRA) using [45]
– Solve nonlinear system (3.3) for steady state solution (using Matlab ode
solver) ⇒ Dn+1LA , Dn+1SA , An+1LA and An+1SA
– Compute the value of the resistances Rn+12a , R
n+1
2b using (3.11);
• Step 3:
– Solve nonlinear system (3.1) for P n+11,post P
n+1
1,2 , P
n+1
4,5 , and P
n+1
5,post (using Mat-
lab nonlinear solver)
– Compute the value of retinal blood flow Qn+1 and the pressures at the
nodes of the system in Figure 3.1 at iteration n+ 1 using Ohm’s law;
• Step 4: Check for convergence of the values of P1,2 and P4,5
max
j={1,2},{4,5}
(
|P n+1j − P nj |
|P n+1j |
)
< φ, (3.12)
where φ is a given tolerance;
• Step 5: If (3.12) is satisfied then the quantities computed at step n+ 1 are the
solution of the coupled model. If (3.12) is not satisfied then set n = n+ 1 and
return to Step 2.
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3.3 Results
Here, we compare model predictions for two different versions of the model: the
(uncoupled) microcirculation model and the coupled model defined in this Chapter.
1. In Sections 3.3.1 and 3.3.2 the coupled model and microcirculation model are
used to predict the blood flow, blood oxygen saturation, and P1,2 and P4,5 values
as the tissue oxygen demand M0 = 1 cm3O2/100cm3/min, and MAP and IOP
vary in the range between (20, 165) mmHg and (7.5, 31) mmHg, respectively.
A comparison between the results of the coupled model and microcirculation
model is presented along with corresponding experimental measurements from
rats [39, 120] and cats [121].
2. In Section 3.3.3 the coupled model is used to predict blood oxygen satura-
tion and blood flow as tissue oxygen demand varies in the range between
(1, 5) cm3O2/100cm3/min, and MAP= 93.3 mmHg, IOP= 15 mmHg andM0 =
2.65 cm3O2/100cm3/min. The model results are compared with clinical data on
flicker stimulation and light-dark stimulation in which oxygen demand varies [30,
32,34–36,122].
3.3.1 Effect of model coupling
The effect of coupling the microcirculation and macrocirculation models is de-
picted in Figure 3.3 by comparing the microcirculation model (black curves) and
coupled model (blue curves) predictions for P1,2 and P4,5 (panel a), the pressure drop
along the CRA (panel b), and the total CRA resistance (panel c) as MAP is varied be-
tween 65 and 165 mmHg and IOP = 15 mmHg. A few key assumptions differ between
the microcirculation model and the coupled model. For example, in the microcircu-
lation model, P4,5 is held fixed (Figure 3.3a). The pressure drop along the CRA (i.e.,
∆PCRA = Pin − P1,2) in the microcirculation model is not directly computed, but is
assumed to be constant (Figure 3.3b), whereas the pressure drop along the CRA in
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Figure 3.3. (a) Model predicted values of P1,2 (solid) and P4,5 (dashed)
for the microcirculation model (black curves) and coupled model (blue
curves). (b) Pressure drop along the CRA for the microcirculation model
(black curve) and coupled model (blue curve). (c) Total resistance in the
CRA in the microcirculation model (black curve) and coupled model (blue
curve). In all panels, MAP is varied between 65 and 165 mmHg, IOP = 15
mmHg and tissue oxygen demand M0 = 1 cm3 O2/100 cm3/min.
the coupled model varies according to the effects of the IOP-RLTp pressure difference
and laminar effects on the CRA. Total resistance in the CRA is computed according
to Ohm’s Law as RCRA = (Pin − P1,2)/Q, where Q is the retinal blood flow through
the system.
Together, the panels in Figure 3.3 provide a mechanical rationale for why the
model predictions for the microcirculation model and coupled model differ substan-
tially, as shown in Figure 3.4.
In Figure 3.4, the predictions for flow and venous oxygen saturation are compared
for the two different models. In both cases, tissue oxygen demand is assumed to be
held constant at 1 cm3 O2/100 cm3/min, MAP ranges from 65 to 165 mmHg, and
IOP = 15 mmHg.
In Figure 3.5, the various mechanisms of VR are turned “on” and “off” to demon-
strate which mechanisms contribute most significantly to generating the VR plateau
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Figure 3.4. (a) Predicted values of retinal blood flow (normalized) as MAP
is varied (65−165 mmHg) using the microcirculation model (black curve)
and coupled model (blue curve). (b) Predicted values for venous oxygen
saturation as MAP is varied (65− 165 mmHg) using the microcirculation
model (black curve) and coupled model (blue curve). Arterial venous
oxygen saturation was assumed to be 0.97 and tissue oxygen demand
M0 = 1 cm3 O2/100 cm3/min. In both panels, IOP = 15 mmHg.
in the coupled model. Consistent with the findings in [45], these results show that
the metabolic and carbon dioxide mechanisms are most important for achieving VR.
3.3.2 Comparison with experimental measurements for changes in MAP
and IOP
To explore which version of the theoretical model (coupled or microcirculation)
yields predictions that more closely mimic reality, predictions using both models are
compared with experimental measurements from rats [39, 120] and cats [121].
In Figure 3.6, normalized values of blood flow are predicted in both the coupled
model and microcirculation model, and compared with data from [39, 120, 121] as
MAP is varied between 20 and 165 mmHg for IOP = 10 mmHg.
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Figure 3.5. Model predicted values of retinal blood flow (normalized)
as MAP is varied (20 − 165 mmHg) using the coupled model. Vascular
regulation mechanisms are turned on and off to assess their individual
contributions. The following combinations are included: all mechanisms
(blue), myogenic + shear + metabolic (green), myogenic + shear + CO2
(red), myogenic + shear (black curve). Here, IOP = 10 mmHg and tissue
oxygen demand M0 = 1 cm3 O2/100 cm3/min.
He et al. [39,120] measure blood flow in rat retina at low-, normal- and elevated-
blood pressure values corresponding to MAP = 59, 108, and 156 mmHg, respectively,
as IOP is varied over a range of 10− 110 mmHg. The coupled model and microcircu-
lation model are only capable of handling IOP values between 7.5 and 31 mmHg, and
these results are compared with the findings from [39,120] in Figure 3.7. In the case
of low MAP, as IOP increases, the diameter of the small arterioles decreases until the
point of collapse, yielding the observed absence of blood flow when IOP > 22 mmHg
(red, solid curve, Figure 3.7).
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Figure 3.6. Normalized values of blood flow predicted by the coupled
model (blue curve) and microcirculation model (black curve) are compared
with data from [39,120] (red open markers) and [121] (magenta triangles)
as MAP is varied between 20 and 165 mmHg for IOP = 10 mmHg and
tissue oxygen demand M0 = 1 cm3 O2/100 cm3/min.
3.3.3 Comparison with experimental measurements for changes in oxygen
demand
Table 3.5 provides a summary of the observed effects of flicker stimulation and
light-dark studies on retinal blood flow, blood oxygen saturation, and vessel diameter
in multiple species (humans, rats, cats, and bullfrogs). These studies do not translate
the degree of flicker stimulation or exposure to light into a quantifiable level of oxygen
demand in the retina. In addition, the observed hemodynamic changes are not the
same across species or for similar flicker stimulation frequencies or light exposure
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Table 3.5.
Summary of vascular response to flicker stimulation and light-dark adap-
tation studies.
Study Species Results Source
Flicker light stimula-
tion
humans - Retinal arterial and venous blood
flow increases during flicker stimula-
tion
[30]
- Major retinal arterial and venous
diameter increases during flicker
stimulation
Flicker light stimula-
tion
humans - Retinal venous oxygen saturation
is higher during flicker stimulation
than in light adaptation
[32]
- Major retinal arterial and ve-
nous diameter increase during flicker
stimulation
Flicker light stimula-
tion
rats - Retinal venous oxygen saturation is
lower during flicker stimulation than
in light adaptation
[122]
Light-dark adaptation humans - Retinal arterial and venous oxygen
saturation is higher during dark than
in light adaptation (in humans)
[34]
- Oxygen consumption in the outer
retina is higher in dark than light
adaptation (in cats)
- Oxygen consumption in the inner
retina is similar in dark than light
adaptation (in cats)
Light-dark adaptation cats - Outer retina tissue oxygen partial
pressure is lower in dark than light
adaptation (in cats)
[36]
- Inner retina tissue oxygen partial
pressure is higher in dark than light
adaptation (in cats)
- Retinal oxygen consumption is
higher in dark than in light adapta-
tion (in bullfrogs)
Light-dark adaptation
and flicker light stimu-
lation
rats - Oxygen consumption in the outer
retina is higher in dark than in light
adaptation
[35]
- Inner retina activity is lower in dark
than in light adaptation
- Retinal blood flow is higher in light
adaptation and during flicker stimu-
lation than in dark adaptation
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Figure 3.7. Coupled model (solid) and microcirculation (dashed) model
predictions of normalized blood flow as IOP is varied between 7.5 − 31
mmHg are compared with experimental measures [39,120] at low-, normal-
and elevated- blood pressure values corresponding to MAP = 59 (red),
108 (blue), and 156 mmHg (black), respectively. Note that these exact
MAP values were provided by authors He et al. since average values
were reported in [120]. All flow values are normalized with respect to the
control state flow value for IOP = 15 mmHg, MAP = 93 mmHg and tissue
oxygen demand M0 = 1 cm3 O2/100 cm3/min.
time. Because of these aspects, these data provide mathematical modelers with a
unique challenge of capturing the various responses according to the geometric and
mechanistic assumptions built into their models.
Figure 3.8 provides a first attempt of using a mathematical model to predict the
change in perfusion when tissue oxygen demand is varied between 1 and 5 cm3 O2/100
cm3/min. The effects of different response mechanisms (myogenic, shear, metabolic,
and carbon dioxide) are evaluated by running multiple model simulations with some
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Figure 3.8. Large arteriole (LA) blood flow vs. oxygen demand. The
model predictions for different vascular regulation mechanisms are com-
pared with clinical data [30] at baseline and during flicker stimulation.
The following combinations are included: all mechanisms (blue curve),
myogenic + shear + metabolic (black), myogenic + shear + CO2 (green),
myogenic + shear (cyan). Here, IOP = 15 mmHg and oxygen consump-
tion varies between 1 and 5 cm3 O2/100 cm3/min.
of the mechanisms active and some inactive. The model predicts asymmetric behavior
in response to changes in tissue oxygen demand. For example, when all mechanisms
are active, the model predicts a 6% decrease in perfusion when tissue oxygen demand
is decreased by 50% and a 23% increase in perfusion when tissue oxygen demand is
increased by 50%. If both the metabolic and carbon dioxide responses are impaired
(light blue line), the model predicts a constant level of blood flow that does not re-
spond to changes in oxygen demand, suggesting the importance of these two response
mechanisms.
73
The predictions of blood flow through a large arteriole are also compared with
data from a study on flicker stimulation in healthy individuals [30] in Figure 3.8. The
clinical study measures: (i) the average value of blood flow in one large retinal arteriole
of 7.4± 3.5 µl/min in light adapted conditions and (ii) a 59% increase in blood flow
with flicker stimulation. In the model, a baseline value for oxygen demand is chosen
to be M0 = 2.65 cm3 O2/100 cm3/min in order to yield the experimentally observed
value of venous blood oxygen saturation of 60% [32]. The M0 value corresponding to
flicker stimulation is obtained from a study showing that flicker stimulation induces
a 48% increase in oxygen demand [122]. Using these clinical data points, Figure 3.8
shows that the model predictions are in good agreement with clinical data.
The model predicted value of oxygen saturation in the large venules is also com-
pared with data from a clinical study on flicker stimulation [32]. The clinical study
measures an increase in venous saturation from 60%±5.7% to 64%±5.9% with flicker
stimulation, while the model predictions show a decrease in venous saturation with
flicker stimulation from 60% to 52%.
3.4 Discussion
The vascular model of the retina developed in this study incorporates the me-
chanical effects of IOP on the CRA and CRV (modeled as compressible tubes) and
four VR response mechanisms to describe blood flow to the retina. The blood flow
predicted by the coupled model is significantly closer to pressure-flow experimental
data collected by [39, 120, 121] than blood flow levels predicted by the microcircu-
lation model, supporting the improvements offered by the coupled model over the
microcirculation model. This excellent agreement between the coupled model and
experiments [39, 120, 121] provides confidence in the model assumptions and equa-
tions.
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3.4.1 Effect of model coupling
The coupled model accounts for the retinal macrocirculation and microcirculation.
The coupling with the macrocirculation model affects the coupled model predictions
which differ from the results obtained with the microcirculation model in the range
of pressures where the VR plateau is absent.
The coupled model and microcirculation model predict significantly different levels
of intraluminal pressure directly upstream and downstream of the microcirculation
compartments (i.e., P1,2 and P4,5, as shown in Figure 3.3a). These differences result
from differing model assumptions: in the microcirculation model P4,5 is held fixed,
while in the coupled model, the passive effects of IOP and compression of the lamina
cribrosa on the diameters of the CRA and CRV cause P1,2 and P4,5 to change. In
addition, in the microcirculation model, the change in pressure along the CRA (i.e.,
∆PCRA = Pin − P1,2, as shown in Figure 3.3b) is not directly computed, but is held
constant at 22 mmHg based on previous model predictions (see Chapter 2 and [45] for
reference). To maintain this constant drop in pressure, the resistance in the CRAmust
decrease significantly (as shown in Figure 3.3c). In contrast, in the coupled model,
the mechanical effects of IOP and the lamina cribrosa dictate ∆PCRA and cause
nonlinear changes in the CRA resistance. As MAP increases, the change in pressure
along the CRA also increases and the resistance of the CRA decreases slightly. The
coupled model and microcirculation model were built to yield the same behavior in
the control state, and thus the P1,2 and P4,5 values are the same for both models
in the control state (as observed by the intersection of the curves at MAP = 93
mmHg in Figure 3.3a). As MAP increases above the control state, ∆PCRA is lower
in the microcirculation model than the coupled model, and the reverse is true when
MAP is decreased below the control state. Together, these relationships explain the
differences in P1,2 and P4,5 predicted by the two models.
Blood flow and oxygen saturation also differ between the coupled model and mi-
crocirculation model. While the two models predict nearly identical VR plateau (Fig-
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ure 3.4a), the change in flow outside the pressure range for VR is more realistic in the
coupled model, as evidenced by its agreement with experimental data (Figure 3.6).
In the microcirculation model, flow is predicted to approach zero at a higher value of
MAP than in the coupled model. Flow will equal zero once ∆P = P1,2−P4,5 = 0. As
can be seen in Figure3.3a, the curves for P1,2 and P4,5 in the microcirculation model
intersect at a higher value of MAP than the coupled model, explaining the faster
decline in flow as MAP decreases.
The differences in flow outside the VR range for each model suggest that the as-
sumptions in the microcirculation model are particularly relevant to study VR while
the model assumptions in the coupled model provide a more accurate description of
the overall hemodynamic behavior of the vascular supply to the retina. Similarly,
the ranges of venous saturation predicted by both models are nearly equivalent (Fig-
ure 3.4b), but the coupled model yields a less steep decline in venous saturation as
MAP decreases than the microcirculation model since blood flow does not decrease as
rapidly. From the results in Figure 3.5, it is also apparent that the combined action of
the metabolic and carbon dioxide responses is important in achieving flow regulation.
3.4.2 Comparison with experimental measurements for changes in MAP
and IOP
The comparison of the microcirculation and coupled model predictions with ex-
perimental data [39, 120, 121] highlights the importance of including the mechanical
effects of IOP and the lamina cribrosa when modeling blood supply to the retina. As
shown in Figure 3.6, the coupled model provides a very close match to experimental
measures of flow in the retina of the rat [39, 120] and cat [121]. It is important to
note that none of the data collected by [39, 120, 121] was used in the formulation or
parameter optimization of this model; rather, the data set is only used to validate
the model, and the agreement between theory and experiment highlights the value of
including both a mechanical description of VR and IOP in the model.
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Figure 3.7 provides further evidence that coupling the macrocirculation and micro-
circulation models is necessary to provide an accurate description of blood flow to the
retina. Model simulations for IOP= 7.5−31 mmHg at low, normal, and elevated MAP
values are compared with experimental data [39,120]. As both the coupled model and
experimental data show, flow is relatively constant (with a slight decrease) over this
range of IOP values. The microcirculation model predicts a much more significant
decrease in flow with IOP which deviates substantially from the collected data. This
decrease is due to the fixed levels of P1,2 and P4,5 (given a specific IOP value) in the
microcirculation model, which leads to a decrease in flow as resistance increases with
IOP. He et al. provide measures for IOP as high as 110 mmHg, but both theoretical
models are limited once IOP is increased beyond a certain threshold (leading to the
closure of the small arterioles in the coupled model). The coupled model is also un-
able to provide predictions for values of MAP or IOP that cause P4,5 = Pout. Of note,
some work is still needed to fully account for the IOP effect (e.g. Starling resistor)
on the retinal venules (SV and LV) and on the CRV.
3.4.3 Comparison with experimental measurements for changes in oxygen
demand
The increase in blood flow predicted by the model due to an increase in oxygen
demand is not in the same proportion as the change in blood flow observed with the
same decrease in oxygen demand, suggesting that vascular regulatory mechanisms
may respond differently to different levels of oxygen demand. In addition, the model
is used to quantify the relevance of the different regulatory mechanisms, suggesting
that metabolic and carbon dioxide responses play a major role in achieving vascular
regulation. While the model is able to quantify the average retinal response to changes
in oxygen demand, it cannot differentiate between the contributions of the inner
and the outer retina. Overall, the preliminary results of this model give important
insight into metabolic flow regulation; however, the inability to capture all of the
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in vivo observations listed in Table 3.5 [32, 34–36] suggests a need for more realistic
descriptions of the retinal geometry and oxygen delivery to explain the response of
blood flow to changes in retinal oxygen demand.
To represent the retinal geometry more accurately, the model can be adapted to
account for the multiple layers (vascular and avascular) of the retina. In this updated
geometry, oxygen will be assumed to diffuse from retinal capillaries and the choroid
into the various retinal tissue layers. The derivation of this extended model will be
presented in Chapter 4.
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4. MODELING OXYGENATION WITHIN MULTIPLE
RETINAL LAYERS
The model presented in this Chapter improves upon the models introduced in Chap-
ters 2 and 3 by including more physiological representations of the following compo-
nents:
• retinal anatomy: the retinal tissue is defined using 6 different layers that include
oxygen sources and sinks;
• vascular architecture: capillaries are arranged in two layers at different depths
providing oxygen to the tissue, together with the choroid (pure diffusion).
• oxygen exchange: the exchange of oxygen occurs through the vessel walls due to
the difference in oxygen concentration between blood and tissue. This boundary
phenomenon requires a new formulation for the oxygen transport problem in
the microcirculation (Section 4.2).
In the next sections we will describe: (i) oxygen transport in the tissue (Sec-
tion 4.1); (ii) oxygen transport in the microvasculature (Section 4.2); (iii) coupling
between parts (i) and (ii) (Section 4.3); (iv) solution algorithm of the coupled problem
(Section 4.4); and (v) preliminary results of numerical simulations (Section 4.5).
4.1 Oxygen transport in the retinal tissue
The retinal tissue is described by the parallelepiped Ωt = Ωxy × (z0, z6) in Fig-
ure 4.1, where Ωxy represents the retinal surface, z0 = 0, and z6 = Lretina, where
Lretina is the total thickness of the retina. The different retinal cells are grouped into
6 different layers according to the retinal anatomy, as depicted in Figure 4.1. Each
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layer is labeled Ωt,j = Ωxy×(zj−1, zj), with j = 1, . . . , 6. The values of the coordinates
z0, . . . , z6 and the measure of Ωxy are reported in Table 4.1.
Layers from 1 − 3 comprise the inner retina and layers 4 − 6 comprise the outer
retina. The thickness of the inner retina Lir and outer retina Lor are assumed to be
equal, yielding Lir = Lor =
Lretina
2
[123].
Layers 2, 4, 5, and 6 are avascular, whereas layers 1 and 3 contain the intermediate
capillary plexus (referred to as C1 in the following sections) and the deep capillary
plexus (referred to as C3 in the following sections), respectively (see Figure 4.1 for
reference).
x
y
z
z0
z1
z2
z3
z4
z5
z6
inner
retina
outer
retina
VITREOUS
CHOROID
Ωxy
LAYER 1
LAYER 2
LAYER 3
LAYER 4
LAYER 5
LAYER 6
ganglion cell and
nerve fiber layer
intermediate capillary plexus (C1)
metabolically active
inner nuclear layer and
inner plexiform layer
metabolically active
outer plexiform layer
deep capillary plexus (C3)
metabolically active
outer nuclear layer
inner segment of
photoreceptors
metabolically active
retinal pigmented
epithelium and outer
segment of photoreceptors
Fibers of Müller
Membrana limitans
interna
Stratum opticum
Ganglionic layer
Inner plexiform layer
Inner nuclear layer
Outer plexiform layer
Outer nuclear layer
Membrana limitans
externa
Layer of rods
and cones
Pigmented layer
Figure 4.1. Left: Tissue layers of the retina clustered in 6 different layers
in the Cartesian coordinate system (x, y, z). Right: Tissue layers of the
retina, by Henry Vandyke Carter, Public Domain, via Wikimedia Com-
mons, from [1], Plate 881.
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The transport of oxygen in the retinal tissue is described by the stationary diffusion
reaction equation in Cartesian coordinates (x, y, z) on Ωt, shown in Figure 4.1
−αtDt∆pt,j = Qj(pt,j, pc,j), in Ωt,j, j = 1, . . . , 6
∂pt,j
∂z
|z0 = 0, on Ωxy × {z = z0}
pt,j|z−j = pt,j|z+j , on Ωxy × {z = zj}, j = 1, . . . , 5
∂pt,j
∂z
|z−j =
∂pt,j
∂z
|z+j , on Ωxy × {z = zj}, j = 1, . . . , 5
pt,j|z6 = pt,choroid, on Ωxy × {z = z6}
n · ∇xypt,j = 0, on ∂Ωxy × (z0, z6),
(4.1)
where αt represents the oxygen solubility coefficient in the tissue, and pt,j represents
the partial pressure of oxygen in the tissue region Ωt,j; thus αtpt,j represents the
oxygen concentration inside the tissue; ∆ is the Laplacian operator,
∂
∂z
is the partial
derivative with respect to the z coordinate, n is the outward normal vector to ∂Ωxy×
(z0, z6) and ∇xy = ∂
∂x
ex +
∂
∂y
ey is the component of the gradient operator (∇)
in the xy plane, where ex and ey are the unit vectors in the x and y direction,
respectively. The quantity pc,j represents the partial pressure of free oxygen inside the
capillaries in the capillary plexus Cj, Dt represents the oxygen diffusion coefficient
in the tissue, and Qj(pt,j, pc,j) represents the supply and consumption term of the
equation. The boundary conditions in system (4.1) enforce: no oxygen flux at the
vitreous level, continuity of partial pressure and flow at the internal interfaces between
layers, Dirichlet condition at the level of the choroid, and no flux lateral condition on
∂Ωxy× (z0, z6). The values of the constants in system (4.1) are reported in Table 4.1.
The reaction term
Qj(pt,j, pc,j) def= Sj(pt,j, pc,j)−Mj(pt,j), (4.2)
is the sum of (i) a source term Sj(pt,j, pc,j) that represents the volumetric flow of
oxygen supplied to the tissue by the capillaries in layers Cj, and (ii) a sink term
Mj(pt,j) that represents the consumption rate of oxygen due to the metabolic activity
81
of the tissue.
Since the only layers containing capillaries are Layers 1 and 3, it follows that
S2 = S4 = S5 = S6 = 0. (4.3)
The explicit form of the source term Sj (j = 1, 3) will be discussed in Section 4.3.
The consumption term Mj(pt,j) is modeled by Michaelis–Menten kinetics [124]
Mj(pt,j) = αt
Λmaxj pt,j
pt,j +K1/2
, (4.4)
where Λmaxj represents the maximum rate of oxygen consumption of the tissue in
layer j, and K1/2 represents the partial pressure of oxygen at half of the maximum
consumption. The maximum rate of oxygen consumption is assumed uniform in the
inner retina, i.e. Λmax1 = Λmax2 = Λmax3 [124]. In the outer retina, the oxygen is
consumed primarily by the photoreceptors (Layer 5 in Figure 4.1). Consumption in
Layers 4 and 6 is considered to be negligible [124, 125]; thus Λmax4 = Λmax6 = 0. The
control state values of the parameters Λmaxj and K1/2 are reported in Table 4.1.
Thus, the form of the reaction term in system (4.1) is:
Qj(pt,j, pc,j) =

Sj(pt,j, pc,j)−Mj(pt,j), j = 1, 3
−Mj(pt,j), j = 2, 5
0, j = 4, 6.
(4.5)
4.1.1 Model reduction
A model reduction of system (4.1) is preformed by averaging the problem on Ωxy,
namely
− 1|Ωxy|
∫
Ωxy
αtDt∆pt,j dσ =
1
|Ωxy|
∫
Ωxy
Qj(pt,j, pc,j) dσ, j = 1, . . . , 6. (4.6)
Here we will define pt,j(z)
def
=
1
|Ωxy|
∫
Ωxy
pt,j dσ as the average value of pt,j at the retinal
depth z, and split the Laplacian operator ∆ into its xy and z components, namely
∆pt,j = ∆xypt,j +
∂2pt,j
∂z2
, where ∆xypt,j =
∂2pt,j
∂x2
+
∂2pt,j
∂y2
. (4.7)
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Table 4.1.
Parameters for the oxygen transport in the retinal tissue
Parameters Value Source
Retinal surface |Ωxy|, cm2 10.9 [126]
Retinal tissue thickness Lretina, µm 250 [124,127]
Inner retina thickness Lir, µm 125 [123]
Outer retina thickness Lor, µm 125 [123]
Thickness of retinal layers
z1 − z0, µm 25 [127]
z2 − z1, µm 75 [127]
z3 − z2, µm 25 [127]
z4 − z3, µm 67.5 [124]
z5 − z4, µm 25 [124]
z6 − z5, µm 32.5 [124]
Oxygen solubility coefficient in tissue αt,
mLO2
mL mmHg
2.4 · 10−5 [128]
Diffusivity of oxygen in tissue Dt, cm2/s 2 · 10−5 [129]
Partial pressure of oxygen at
80 [128]
the level of the choroid pt,choroid, mmHg
Maximum rate of oxygen consumption Λmaxj
Layer 1− 3, mmHg/s 26 [124]
Layer 4, 6, mmHg/s 0 [124,125]
Layer 5, mmHg/s 90 [124]
Partial pressure of oxygen at half
2 [130]
maximum consumption K1/2, mmHg
The integral on left hand side (4.6) becomes (up to a negative sign):
1
|Ωxy|
∫
Ωxy
αtDt∆pt,j dσ =
1
|Ωxy|
∫
Ωxy
αtDt∆xypt,j dσ +
1
|Ωxy|
∫
Ωxy
αtDt
∂2pt,j
∂z2
dσ
1
=
αtDt
|Ωxy|
∫
Ωxy
∆xypt,j dσ + αtDt
d2
dz2
1
|Ωxy|
∫
Ωxy
pt,j dσ
=
αtDt
|Ωxy|
∫
Ωxy
∇xy · (∇xypt,j) dσ + αtDt
d2pt,j
dz2
2
=





αtDt
|Ωxy|
∫
∂Ωxy
n · ∇xypt,j dσ + αtDt
d2pt,j
dz2
, j = 1, . . . , 6,
(4.8)
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where in step 1 the z component of the Laplacian operator can be moved outside of
the integral since Ωxy is assumed uniform in z, and in step 2 the first term becomes
an integral on ∂Ωxy using the divergence theorem. This term is zero due to the no
lateral flux boundary condition in (4.1).
The right hand side of equation (4.6) becomes:
1
|Ωxy|
∫
Ωxy
Qj(pt,j, pc,j) dσ = Qj(pt,j, pc,j), j = 1, . . . , 6, (4.9)
where Qj(pt,j, pc,j) = Sj(pt,j, pc,j)−M j(pt,j). The computation of the functional form
of Sj (j = 1, . . . , 6) will be discussed in Section 4.3 (equation (4.48)). The average
oxygen consumption M is computed via a linear approximation as follows:
M j(pt,j) =
1
|Ωxy|
∫
Ωxy
αt
Λmaxj pt,j
pt,j +K1/2
dσ ' αt
Λmaxj pt,j(z)
pt,j(z) +K1/2
= Mj(pt,j), (4.10)
for z ∈ (zj−1, zj), and j = 1, . . . , 6. The result of this averaging procedure is summa-
rized in the following system which describes the transport of oxygen in the retinal
tissue through the depth of the retina thickness (coordinate z):
−αtDt
d2pt,j
dz2
,= Qj(pt,j, pc,j), in (zj−1, zj), j = 1, . . . , 6
dpt,j
dz
|z0 = 0, at z = z0
pt,j|z−j = pt,j|z+j , at z = zj, j = 1, . . . , 5
dpt,j
dz
|z−j =
dpt,j
dz
|z+j , at z = zj, j = 1, . . . , 5
pt,j|z6 = pt,choroid, at z = z6.
(4.11)
The function pt,j = pt,j(z), thus the partial derivatives with respect to the z coordinate
in (4.1) become ordinary derivatives.
4.2 Oxygen transport in the retinal microvasculature
The retinal microcirculation model, presented in Chapter 3, is modified by split-
ting the single capillary compartment in Figure 3.1 into two capillary compartments
C1 and C3 located inside tissue Layers 1 and 3, respectively. It is assumed that 35%
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(ψ1 = 0.35) of the total number of small arterioles and small venules branch into the
intermediate capillary plexus (i.e., into tissue layer 1), and that 65% (ψ2 = 0.65) of
the total number of small arterioles and small venules branch into the deep capillary
plexus (i.e., into tissue layer 3). The ratio between the total number of capillaries in
compartments C1 and C3 is therefore equal to
ψ1
ψ2
. To ensure similar hemodynamic
conditions in the two capillary compartments, the total blood flow is split using the
same proportionality constant, namely:
total blood flow comp. C1 = ψ1 ∗ (total retinal blood flow)
total blood flow comp. C3 = ψ2 ∗ (total retinal blood flow).
(4.12)
A depiction of this updated microcirculation model is shown in Figure 4.2. The values
of ψ1 and ψ2 are physiologically reasonable and similar to those used in [127], where
ψ1 = 30%, ψ2 = 60% and the remaining 10% of arteries and veins were located at the
level of the vitreous, and did not branch into capillaries. Here we do not account for
the arterioles and veins that remain at the level of the vitreous.
LA SA
VITREOUS
C1
C3
SV LV
CRA CRV
tissue Layer 1
tissue Layer 2
tissue Layer 3
tissue Layers 4− 6
Figure 4.2. Retinal microvasculature represented by the following com-
partments: the large arterioles (LA), small arterioles (SA), intermedi-
ate capillaries (C1), deep capillaries (C3), small venules (SV), and large
venules (LV). The central retinal artery (CRA) is upstream of the model,
and central retinal vein (CRV) is downstream of the model.
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Let us now focus on the transport of oxygen inside a vessel of the retinal microcir-
culation, such as that shown in Figure 4.3. The cylinder of length L and radius r with
circular cross-section Σ in the polar coordinate system (ζ, θ, s) is used to represent a
generic vessel in any of the microcirculation compartments depicted in Figure 4.2.
s
r
Σ
ζ
θ
s = 0 s = L
Σ
Figure 4.3. Representative cylinder Ω in cylindrical coordinates (ζ, θ, s)
with circular cross-section Σ, of length L and radius r.
Oxygen transport is described by the stationary advection diffusion reaction equa-
tion in cylindrical coordinates on the domain Ω = [0, r) × [0, 2pi) × (0, L) shown in
Figure 4.3, namely
∇ · J = ϕ, in Ω, (4.13)
where:
• J def= uc−D∇c, is the oxygen flux; J = Jζeζ + Jθeθ + Jses, where eζ , eθ and es
are the unit vectors in the ζ, θ and s (axial) direction, respectively;
• u is the blood velocity, u = uζeζ + uθeθ + uses;
• c def= αcpc + HDc0SO2 is the total oxygen concentration in the blood, which is
the sum of (i) the oxygen dissolved in plasma and red blood cells (RBCs),
denoted by αcpc, and (ii) the oxygen bound to hemoglobin in RBCs, denoted
by HDc0SO2 . The quantities pc and SO2 represent the partial pressure of free
oxygen and the blood oxygen saturation, respectively. Oxygen saturation is
related to pc through the Hill equation
SO2 =
pnHc
pnHc + p
nH
50
, (4.14)
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where nH is the Hill coefficient and p50 is the partial pressure of free oxygen at
50% saturation.
The constants αc, HD and c0 are the oxygen solubility coefficient, blood hemat-
ocrit and oxygen carrying capacity of the RBCs, respectively. Blood is modeled
as a mixture of plasma and RBCs, therefore the solubility coefficient αc is com-
puted as the weighted average of the plasma and RBC contributions:
αc = HDα1 + (1−HD)α2, (4.15)
where α1 represents the oxygen solubility in the RBCs and α2 represents the
oxygen solubility in plasma. The values of αc, c0, HD, α1, α2, p50, and nH are
reported in Table 4.2;
• D is the diffusivity tensor;
• ϕ is an oxygen sink or source in Ω.
Table 4.2.
Parameters for the oxygen transport in the retinal microvasculature
Parameters Value Source
Hematocrit HD 0.4 [131]
Oxygen carrying capacity of RBCs c0, mL O2/mL 0.5 [131]
Oxygen solubility coefficient in RBCs α1,
mL O2
mL mmHg
3.38 · 10−5 [132]
Oxygen solubility coefficient in plasma α2,
mL O2
mL mmHg
2.82 · 10−5 [132]
Diffusivity of oxygen in plasma Dζ , cm2/s 2.18 · 10−5 [133]
Diffusivity of hemoglobin in RBCs DHb, cm2/s 1.5 · 10−7 [134]
Partial pressure of free oxygen at 50% saturation p50, mmHg 26 [131]
Hill coefficient nH 2.7 [131]
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Starting from (4.13), we will perform a model reduction using the following as-
sumptions:
• D is diagonal;
D =

Dζ 0 0
0 Dθ 0
0 0 Ds
 (4.16)
where Dζ , Dθ and Ds represent the diffusivity coefficients in the radial, angular
and axial coordinate, respectively;
• The right hand side of equation (4.13) is null, namely ϕ = 0, since no sources
or sinks of oxygen are present in Ω. The exchange of oxygen, which filtrates
through the vessel walls into the tissue, is modeled through the boundary con-
ditions;
• There is no dependence on the θ-coordinate ⇒ ∂ ·
∂θ
= 0, Jθ = 0, uθ = 0;
• A parabolic velocity profile à la Poiseuille is assumed ⇒ uζ = 0 ⇒ Jζ =uζc−
Dζ
∂c
∂ζ
, and us = 0 at ζ = r;
• The contribution of hemoglobin radial diffusion in RBCs is neglected;
Jζ = −Dζ ∂c
∂ζ
= −Dζ ∂
∂ζ
(
αcpc +




DHb
Dζ
HDc0SO2
)
, (4.17)
where DHb represents the diffusivity of hemoglobin in RBCs.
• The contribution of oxygen diffusion in the axial direction is negligible compared
to the advective component ⇒
Js = usc−
((((
((((
((((
((((
Ds
∂
∂s
(
αcpc +
DHb
Ds
HDc0SO2
)
, (4.18)
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The values of the constants Dζ and DHb are reported in Table 4.2.
Given these assumptions, the term ∇ · J in equation (4.13) becomes:
∇ · J = 1
ζ
∂
∂ζ
(
ζJζ
)
+
1
ζ
(
∂Jθ
∂θ
)
+
∂Js
∂s
= −1
ζ
∂
∂ζ
[
ζDζ
∂(αcpc)
∂ζ
]
+
∂
∂s
[
us (αcpc +HDc0SO2)
]
.
(4.19)
In this model, the exchange of oxygen between the blood vessel and the surrounding
tissue is driven by the difference between the concentration of oxygen inside the vessel
and the concentration of oxygen in the tissue surrounding the vessel. This physiolog-
ical phenomenon is described by the wall-free model presented in [135] through the
boundary condition of the system (4.20). Using the wall-free technique, the effect of
the vessel wall is captured by the permeability coefficient Lp, yielding
−1
ζ
∂
∂ζ
[
ζDζ
∂(αcpc)
∂ζ
]
+
∂
∂s
[
us (αcpc +HDc0SO2)
]
= 0, in Ω
−Dζ ∂(αcpc)
∂ζ
|ζ=r = Lp(αcpc|ζ=r − αtpt,w), on Γ1 = {r} × [0, 2pi)× (0, L)
pc = pˆc,0, on Σ0 = [0, r)× [0, 2pi)× {0}.
(4.20)
The quantity pt,w represents the partial pressure of oxygen in the tissue surrounding
the vessel, and pˆc,0 represents the partial pressure profile at the cylinder inlet. The
parameter Lp regulates the exchange of oxygen between the blood inside the vessel and
the surrounding tissue. The clinical literature does not provide a range of values for
Lp; thus in this work, the value of the parameter is estimated to yield physiologically
reasonable oxygen concentration profiles in the mathematical simulations. The value
of the parameter Lp is reported in Table 4.3.
4.2.1 Model reduction
A model reduction of the system (4.20) is performed by integrating over the cross-
section Σ = [0, r)× [0, 2pi). Further assumptions on us, pc and SO2 are necessary. It
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is assumed that the dependence on ζ and s for each of the quantities of interest
can be expressed as the product of (i) the quantity cross-sectional average (overlined
function) that depends on the axial coordinate s only, and (ii) a shape function f
that depends on the radial component ζ only. So we write:
us(ζ, s) = us(s)fu(ζ), where us(s) =
1
pir2
∫ 2pi
0
∫ r
0
us ζ dζ dθ
pc(ζ, s) = pc(s)fp(ζ), where pc(s) =
1
pir2
∫ 2pi
0
∫ r
0
pc ζ dζ dθ
SO2(ζ, s) = SO2(s)fSO2 (ζ), where SO2(s) =
1
pir2
∫ 2pi
0
∫ r
0
SO2 ζ dζ dθ.
(4.21)
The shape function can be computed explicitly by enforcing compatibility with the
boundary conditions. The assumption of Poiseuille flow for the blood implies
i Parabolic profile of us ⇒ fu(ζ) = aζ2 + bζ + c.
ii The maximum value of us is attained at ζ = 0 ⇒ f ′u(ζ)|0 = 0
f ′u(ζ)|0 = (2aζ + b)|0 = 0 ⇒ b = 0. (4.22)
iii fu(ζ)|r = 0 ⇒ ar2 + c = 0 ⇒ c = −ar2.
The separation of variables in equation (4.21) implies that fu(ζ) must satisfy∫ 2pi
0
∫ r
0
fu(ζ)ζ dζ dθ = pir
2, (4.23)
which implies that,
pir2 =
∫ 2pi
0
∫ r
0
fu(ζ)ζ dζ dθ =
∫ 2pi
0
∫ r
0
a(ζ2 − r2)ζ dζ dθ = 2pia
[
ζ4
4
− ζ
2r2
2
]r
0
a = − 2
r2
, ⇒ c = 2.
(4.24)
Therefore fu(ζ) = 2
(
1− ζ
2
r2
)
, which corresponds to the classic Poiseuille profile.
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The boundary condition for the partial pressure of oxygen pc in system (4.20)
requires additional attention. Replacing pc in the second condition of system (4.20)
with the expression in (4.21) gives:
−Dc ∂(αcpc)
∂ζ
|Γ1 = Lp(αcpc|Γ1 − αtpt,w)
−Dc ∂(αcpc(s)fp(ζ))
∂ζ
|Γ1 = Lp(αcpc(s)fp(ζ)|Γ1 − αtpt,w)
−Dcαcpc(s)f ′p(r) = Lp(αcpc(s)fp(r)− αtpt,w).
(4.25)
This is a differential equation for fp(r) that can be solved if the dependence on the
coordinate s is eliminated. To this end we define the function
p∗(ζ, s) = pc(ζ, s)− βpt,w(s), where β def= αt
αc
, (4.26)
representing an extension of the tissue oxygen partial pressure pt,w from the vessel
wall into Ω [127,136]. Note that pt,w is assumed to be constant on each cross-section
and so it does not depend on ζ. Consistent with the equations (4.21), it is assumed
that
p∗(ζ, s) = p∗(s)f ∗(ζ), (4.27)
and so pc(s)fp(ζ) = p∗(s)f ∗(ζ)+βpt,w(s). Moreover, since
∫ 2pi
0
∫ r
0
f ∗(ζ)ζ dζ dθ = pir2
we can write
pc(s) =
1
pir2
∫ 2pi
0
∫ r
0
pc(ζ, s)ζ dζ dθ =
1
pir2
∫ 2pi
0
∫ r
0
[
p∗(s)f ∗(ζ) + βpt,w(s)
]
ζ dζ dθ
=
1
pir2
(
p∗(s)pir2 + βpt,w(s)pir2
)
= p∗(s) + βpt,w(s).
(4.28)
Consider the candidate shape function f ∗(ζ) =
k + 2
k + 2(1− δ)
(
1− δ ζ
k
rk
)
, where
k and δ are arbitrary constants [136] that can be chosen so that f ∗(ζ) satisfies the
second equation in (4.20). We verify the compatibility of f ∗(ζ) with the second
equation in (4.20) and with condition (4.23) in the following way:
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i ∫ 2pi
0
∫ r
0
f ∗(ζ)ζ dζ dθ =
∫ 2pi
0
∫ r
0
k + 2
k + 2(1− δ)
(
1− δ ζ
k
rk
)
ζ dζ dθ
= 2pi
k + 2
k + 2(1− δ)
[
ζ2
2
− δ
rk
ζk+2
k + 2
]r
0
= 2pi
k + 2
k + 2(1− δ)
(
r2
2
− δ
 rk
rk+2
k + 2
)
= 2pi
k + 2
k + 2(1− δ)
2r2 + kr2 − 2δr2

2(k + 2)
= pir2(
((((
((k + 2(1− δ)
((((
(((k + 2(1− δ) .
(4.29)
ii Assuming a parabolic profile for f ∗(ζ), we set k = 2. Thus
f ∗(ζ) =
2
2− δ
(
1− δ ζ
2
r2
)
, f ∗(r) =
2(1− δ)
2− δ ,[
f ∗(ζ)
]′
= − 4δζ
(2− δ)r2 ,
[
f ∗(r)
]′
= − 4δ
(2− δ)r ,
(4.30)
iii The last step is to determine the value of δ such that the second equation
in (4.20) is verified:
−Dζ ∂(αcpc)
∂ζ
|Γ1 = Lp(αcpc|Γ1 − αtpt.w)
−Dζ ∂(αcpc)
∂ζ
|Γ1 = Lp(αcpc − αtpt.w)|Γ1
−αcDζ ∂(p
∗ + βpt.w)
∂ζ
|Γ1 =αcLp(p∗)|Γ1
−Dζ ∂p
∗
∂ζ
|Γ1 +


*
pt,w=pt,w(s)
Dζ
∂βpt.w
∂ζ
|Γ1 = Lp(p∗)|Γ1
−Dζ ∂(
p∗(s)f ∗(ζ))
∂ζ
|Γ1 = Lp(p∗(s)f ∗(ζ))|Γ1
−Dζ [f ∗]′ (r) = Lpf ∗(r) ⇒ 4δDζ
(2− δ)r = Lp
2(1− δ)
2− δ
δ =
Lpr
2Dζ + Lpr (δ 6= 2).
(4.31)
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The function f ∗(ζ) =
2
2− δ
(
1− δ ζ
2
r2
)
, with δ defined by (4.31) is compatible
with the wall-free boundary condition and satisfies equation (4.23). Therefore this
function is chosen to be the shape function for p∗(ζ, s) in (4.27).
Oxygen saturation (SO2) is computed using the Hill equation as a function of the
free oxygen partial pressure (pc) and it is related to the oxygen bound to hemoglobin
in the RBCs. This current work does not focus on the spatial distribution of RBCs
inside of the vessel lumen; thus oxygen saturation is assumed to be a function of pc
and fSO2 (ζ) ≡ 1. In this way, condition (4.23) is automatically verified by fSO2 (ζ),
and
SO2(ζ, s) = SO2(s)
def
=
pnHc (s)
pnHc (s) + p
nH
50
. (4.32)
Now let’s substitute p∗ into system (4.20) and then proceed to the model reduction
−1
ζ
∂
∂ζ
[
ζDζ
∂(αc(p
∗ + βpt,w))
∂ζ
]
+
∂
∂s
[
us
(
αc(p
∗ + βpt,w) +HDc0SO2
)]
= 0, in Ω
−Dζ ∂(αc(p
∗ + βpt,w))
∂ζ
= Lpαcp∗, on Γ1
p∗ = pˆc,0 − βpt,w, on Σ0.
(4.33)
The cross-sectional integration of the radial diffusive contribution in (4.33) gives∫ 2pi
0
∫ r
0
−1
ζ
∂
∂ζ
[
ζDζ
∂(αc(p
∗ + βpt,w))
∂ζ
]
ζ dζ dθ = −2pi
[
ζDζ
∂(αc(p
∗ + βpt,w))
∂ζ
]r
0
= −2pirDζ ∂(αc(p
∗ + βpt,w))
∂ζ
|Γ1
= 2pirαcLpp∗|Γ1
= 2pirαcLpp∗(s)f ∗(r),
(4.34)
and the cross-sectional integration of the axial contribution in (4.33) gives∫ 2pi
0
∫ r
0
∂
∂s
[
us
(
αc(p
∗ + βpt,w) +HDc0SO2
)]
ζ dζ dθ. (4.35)
The integral in (4.35) is the sum of three contributions:
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1.
∫ 2pi
0
∫ r
0
∂
∂s
[αcusp
∗] ζ dζ dθ =
d
ds
∫ 2pi
0
∫ r
0
[
us(s)fu(ζ)αcp
∗(s)f ∗(ζ)
]
ζ dζ dθ
= αc
d
ds
(
us(s)p
∗(s)
) ∫ 2pi
0
∫ r
0
[
fu(ζ)f
∗(ζ)
]
ζ dζ dθ
= αc
d
ds
(
us(s)p
∗(s)
)
pir2ωu∗,
(4.36)
where
ωu∗
def
=
1
pir2
∫ 2pi
0
∫ r
0
[
fu(ζ)f
∗(ζ)
]
ζ dζ dθ
=
1
pir2
∫ 2pi
0
∫ r
0
2(1− ζ2
r2
)
2
2− δ
(
1− δ ζ
2
r2
) ζ dζ dθ
=
8pi
(2− δ)pir2
∫ r
0
(
δ
ζ5
r4
− (1 + δ)ζ
3
r2
+ ζ
)
dζ
=
8
(2− δ)r2
[
δ
ζ6
6r4
− (1 + δ) ζ
4
4r2
+
ζ2
2
]r
0
=
8
(2− δ)r2
(
2δ − 3− 3δ + 6
12r4
)
r6 =
2(3− δ)
3(2− δ) .
(4.37)
2.
∫ 2pi
0
∫ r
0
∂
∂s
[
αcβuspt,w
]
ζ dζ dθ =
d
ds
∫ 2pi
0
∫ r
0
[
αcβus(s)fu(ζ)pt,w(s)
]
ζ dζ dθ
= αcβ
d
ds
(
us(s)pt,w(s)
) ∫ 2pi
0
∫ r
0
[
fu(ζ)
]
ζ dζ dθ
= αcβ
d
ds
(
us(s)pt,w(s)
)
pir2.
(4.38)
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3. ∫ 2pi
0
∫ r
0
∂
∂s
[usHDc0SO2 ] ζ dζ dθ =
d
ds
∫ 2pi
0
∫ r
0
[
HDc0us(s)fu(ζ)SO2(s)
]
ζ dζ dθ
= HDc0
d
ds
(
us(s)SO2(s)
)∫ 2pi
0
∫ r
0
[
fu(ζ)
]
ζ dζ dθ
= HDc0
d
ds
(
us(s)SO2(s)
)
pir2.
(4.39)
Notice that in (4.36), (4.38), and (4.39) the partial derivative with respect to s
can be moved outside of the double integral since the cross-section Σ does not depend
on the axial coordinate s. In addition, outside of the integral the partial derivative
becomes a total derivative with respect to s, since the double integral removes the
dependence from the radial coordinate ζ.
The sum of (4.34), (4.36), (4.38), and (4.39) gives:
d
ds
[
us(s)pir
2
(
αcp
∗(s)ωu∗ + αcβpt,w(s) +HDc0SO2(s)
)]
+ 2pirαcLpp∗(s)f ∗(r) = 0,
(4.40)
where the second equation in (4.20) is now included in (4.40) as a reaction term.
The term us(s)pir2 = Qc(s) is equal to the blood flow in the vessel Ω. Note that
Qc is determined by the vascular resistance and the pressure drop along the vessel
(see Ohm’s law in Chapter 2 for reference), and so it does not depend on the axial
coordinate s. Thus, equation (4.40) is written as:
Qc
d
ds
[(
αcp
∗(s)ωu∗ + αcβpt,w(s) +HDc0SO2(s)
)]
+ 2pirαcLpp∗(s)f ∗(r) = 0. (4.41)
To complete the model reduction procedure, equation (4.40) is written in terms of
the original variable pc:
Qc
d
ds
(
αcpc(s)ωu∗ +HDc0SO2(s)
)
+
+Qc
d
ds
(
αcβ (1− ωu∗) pt,w
)
+
+2pirαcLp
(
pc(s)− βpt,w
)
f ∗(r) = 0, for s ∈ (0, L)
pc(0) = pc,0,
(4.42)
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where pc,0 is the value of pc when s = 0. System (4.42) describes the reduced one
dimensional problem for the transport of oxygen in one vessel of the retinal microcir-
culation depicted in Figure 4.2 and 4.3.
4.3 Coupling between retinal tissue and retinal microvasculature
To describe the oxygenation of the retinal microvasculature and the retinal tissue,
the systems are coupled using the following procedure:
The first equation in system (4.42) is written for every compartment in Figure 4.2:
Qc,j
d
ds
(
αcpc,j(s)ωu∗,j +HDc0SO2,j(s)
)
+
+Qc,j
d
ds
(
αcβ
(
1− ωu∗,j
)
pt,w,j
)
+
+2pirjαcLp,j
(
pc,j(s)− βpt,w,j
)
f ∗j (rj) = 0,
for s ∈ (0, Lj), j = LA,SA,C1,C3,SV,LV,
(4.43)
where the subscript j denotes the compartment where each quantity is computed.
The values of the quantities introduced in equation (4.43) are reported in Table 4.3.
Table 4.3.
Geometrical and physiological parameter of the network in Figure 4.2
Parameters VALUE Source
LA SA C1 C3 SV LV
radius r, µm 52.8 24 3 3 34.8 77.8 ch. 3
Length L, cm 0.59 0.43 0.054 0.054 0.43 0.59 ch. 3
Number of vessels N 4 38 66910 124262 38 4 ch. 3
Permeability coefficient Lp, 10−4 cm/s 0.5 1.1 21.6 21.6 0 0 -
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The quantity pt,w,j in equation (4.43) represents the partial pressure of oxygen in
the tissue surrounding the vessels in compartment j and is computed as follows:
pt,w,j = pt,1(z = 0) for j = LA,SA,SV,LV
pt,w,j =
∼
pt,j for j = C1,C3
where: ∼pt,C1
def
=
1
z1 − z0
∫ z1
z0
pt,1(z) dz
∼
pt,C3
def
=
1
z3 − z2
∫ z3
z2
pt,3(z) dz.
(4.44)
For compartments LA, SA, SV, and LV, the quantity pt,w,j is set equal to the value
of partial pressure of oxygen at the level of the vitreous, while in compartments C1
and C3, the quantity pt,w,j is equal to the average of pt,j computed along the tissue z
coordinate, as shown in (4.44).
The modeling choices for pt,w,j, summarized in (4.44), imply that the quantity
does not depend on the axial coordinate s, so
dpt,w,j
ds
= 0, j = LA,SA,C1,C3,SV,LV, (4.45)
The last term of equation (4.43) represents an oxygen volumetric rate per unit of
length and is defines as:
qj(s)
def
= 2pirjαcLp,j
(
pc,j(s)− βpt,w,j
)
f ∗j (rj), for j = LA,SA,C1,C3,SV,LV. (4.46)
Following the same assumptions of the model described in Chapter 3, it is assumed
that compartments SV and LV do not exchange oxygen with the surrounding tissue.
This assumption is implemented by setting Lp,SV = 0 and Lp,LV = 0, as reported in
Table 4.3. This implies that qSV (s) ≡ 0 and qLV (s) ≡ 0.
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Combining (4.43), (4.44), (4.45), and (4.46) into system (4.42) gives:
Qc,j
d
ds
(
αcpc,j(s)ωu∗,j +HDc0SO2,j(s)
)
= −qj(s), s ∈ (0, Lj],
pc,LA(0) = pc,0,
NLAQc,LAcLA(LLA) = NSAQc,SAcSA(0),
NSAQc,SAcSA(LSA) = NC1Qc,C1cC1(0) +NC3Qc,C3cC3(0),
cC1(0) = cC3(0),
NC1Qc,C1cC1(LC1) +NC3Qc,C3cC3(LC1) = NSVQc,SV cSV (0),
NLAQc,SV cSV (LSV ) = NLVQc,LV cLV (0),
(4.47)
where cj(s) = αcpc,j(s)ωu∗,j +HDc0SO2,j(s), and Nj is the number of parallel vessels
in the compartment j, with j = LA,SA,C1,C3,SV,LV. The last five equations in sys-
tem (4.47) guarantee the conservation of oxygen between the different compartments.
To conclude the coupling procedure between the retinal tissue and the retinal
microcirculation, we provide the explicit formulation of the sources of oxygen in the
j-th retinal layer, Sj in (4.11) where j = 1, 3,
S1 def= NC1
(z1 − z0) |Ωxy|
∫ LC1
0
qC1(s) ds, S3 def= NC3
(z3 − z2) |Ωxy|
∫ LC3
0
qC3(s) ds.
(4.48)
4.4 Solution algorithm
Let us define the linearized quantities Mˆ and SˆO2 .
The nonlinear consumption term M i(pt,i) (i = 1, . . . , 6) in equation (4.10) is lin-
earized as follows:
Mi(pt,i) = αt
Λmaxi pt,i(z)
pt,i(z) +K1/2
=
αtΛ
max
i
pt,i(z) +K1/2
pt,i(z) = Mˆi(pt,i) pt,i(z), (4.49)
where Mˆi(pt,i)
def
=
αtΛ
max
i
pt,i(z) +K1/2
, and z ∈ (zj−1, zj), j = 1, . . . , 6.
The oxygen saturation SO2,j(s) (j = LA,SA,C1,C3,SV,LV) in (4.42) is linearized
as follows:
SO2,j(s) =
pnHc,j
pnHc,j + p
nH
50
=
pnH−1c,j
pnHc,j + p
nH
50
pc,j = SˆO2,j(pc,j)pc,j(s), (4.50)
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where SˆO2,j(pc,j)
def
=
pnH−1c,j
pnHc,j + p
nH
50
.
Consider the coupled problem consisting of the nonlinear systems (4.11) and (4.47).
The coupled problem is solved following the algorithm depicted in Figure 4.4. The
algorithm consists of two nested fixed point iterations. The outer loop (index k)
enforces the conservation of mass between the two systems while the inner loops
(indexes n and m) solve the nonlinear problems of the transport of oxygen in the
microcirculation and in the tissue systems.
The algorithm proceed as follows:
Given the values of Qc,j and ωu∗,j, and the initial guess for p0c,j(s) s ∈ [0, Lj]
(j = LA, . . . ,LV) and p0t,i(z) z ∈ [zi−1, zi] (i = 1, . . . , 6):
• Step 1: Compute q0j (s) (j = LA, . . . ,LV) and S0i (i = 1, 3) with formula (4.46)
and (4.48), respectively;
for k ≥ 0
• Step 2:
– Set n = 1 and pk,0c,j (s) = pkc,j(s) , (j = LA, . . . ,LV)
– Set m = 1 and pk,0t,i (s) = pkt,i(s) , (i = 1, . . . , 6);
for n ≥ 1 and m ≥ 1
• Step 3: (j = LA, . . . ,LV)
− Set pk,nc,j (s) = pk,n−1c,j (s)
− Compute Sˆk,nO2,j(s) =
(
pk,nc,j (s)
)nH−1
(
pk,nc,j (s)
)nH
+ pnH50
;
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initialize: k = 0
given: p0c,j(s) s ∈
[
0, Lj
]
p0t,i(z) z ∈ [zi−1, zi]
compute: qoj (s) s ∈
[
0, Lj
]
S0i
oxygen transport
in microcirculation
set pk,nc,j = p
k,n−1
c,j
compute Sˆk,nO2j
solve (4.51)⇒ pk,n+1c,j
oxygen transport
in retinal tissue
set pk,mt,i = p
k,m−1
t,i
compute Mˆk,ni
solve (4.53)⇒ pk,m+1t,i
e(pk,n+1c,j , p
k,n
c,j ) < φc,j e(p
k,m+1
t,i , p
k,m
t,i ) < φt,i
update:
compute pk+1c,j
compute pk+1t,i
compute qk+1j
compute Sk+1i
e(qk+1j , q
k
j ) < φq,j
e(Sk+1i ,S
k
i ) < φS,i
e(pk+1c,j , p
k
c,j) < φc,j
e(pk+1t,i , p
k
t,i) < φt,i
stop:
pc,j = p
k+1
c,j
pt,i = p
k+1
t,i
n = 1, pk,0c,j = p
0
c,j m = 1, p
k,0
t,i = p
0
t,i
no
n = n+ 1
no
m = m+ 1
yes yes
yes
no
k = k + 1
n = 1
set pk,0c,j = pkc,j
no
k = k + 1
m = 1
set pk,0t,i = pkt,i
Figure 4.4. Schematic of the solution algorithm for the coupled problem
of oxygen transport. In the diagram j =LA,SA,C1,C3,SV,LV and i =
1, . . . , 6.
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• Step 4: Solve the linearized version of system (4.47) for pk,n+1c,j (s)
Qc,j
d
ds
(
αcp
k,n+1
c,j (s)ωu∗,j +HDc0Sˆ
k,n
O2,j
(s)pk,n+1c,j (s)
)
= −qkj (s), s ∈ (0, Lj],
pk,n+1c,LA (0) = p
k,n
c,LA(0),
NLAQc,LAc
k,n+1
LA (LLA) = NSAQc,SAc
k,n+1
SA (0),
NSAQc,SAc
k,n+1
SA (LSA) = NC1Qc,C1c
k,n+1
C1 (0) +NC3Qc,C3c
k,n+1
C3 (0),
ck,n+1C1 (0) = cC3(0)
k,n+1,
NC1Qc,C1c
k,n+1
C1 (LC1) +NC3Qc,C3c
k,n+1
C3 (LC1) = NSVQc,SV c
k,n+1
SV (0),
NLAQc,SV c
k,n+1
SV (LSV ) = NLVQc,LV c
k,n+1
LV (0),
(4.51)
where ck,n+1j (s) = αcp
k,n+1
c,j (s)ωu∗,j+HDc0Sˆ
k,n
O2,j
(s)pk,n+1c,j (s), and j = LA, . . . ,LV;
• Step 5: Check convergence of the solution of (4.51):
e(pk,n+1c , p
k,n
c ) = max
j=LA,...,LV
[
maxs∈[0,Lj ] |pk,n+1c,j (s)− pk,nc,j (s)|
maxs∈[0,Lj ] |pk,n+1c,j (s)|
]
< φc, (4.52)
where φ is a given tolerance;
• Step 6: If (4.52) is satisfied go to Step 7. If (4.52) is not satisfied, then
set n = n+ 1 and return to Step 3;
• Step 7: (i = 1, . . . , 6)
− Set pk,nt,i (z) = pk,n−1t,i (z)
− Compute Mˆk,nj (z) =
αtΛ
max
i
pk,nt,i (z) +K1/2
;
• Step 8: Solve the linearized version of system (4.11) for pk,n+1t,i (z)
−αtDt
d2pk,n+1t,i
dz2
,= Ski − Mˆk,ni pk,n+1t,i , in (zj−1, zj), i = 1, . . . , 6
dpk,n+1t,i
dz
|z0 = 0, at z = z0
pk,n+1t,i |z−i = p
k,n+1
t,i |z+i , at z = zi, i = 1, . . . , 5
dpk,n+1t,i
dz
|z−i =
dpk,n+1t,i
dz
|z+i , at z = zi, i = 1, . . . , 5
pk,n+1t,i |z6 = pt,choroid, at z = z6;
(4.53)
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• Step 9: Check convergence of the solution of (4.53):
e(pk,n+1t , p
k,n
t ) = max
i=1,...,6
[
maxz∈[zi−1,zi] |pk,n+1t,i (z)− pk,nt,i (z)|
maxz∈[zi−1,zi] |pk,n+1t,i (z)|
]
< φt (4.54)
where φ is a given tolerance;
• Step 10: If (4.54) is satisfied go to Step 11. If (4.54) is not satisfied, then
set m = m+ 1 and return to Step 7;
• Step 11:
– Update the variables in the fixed point iterations on the index k using the
relaxation method with parameters λc and λt ∈ (0, 1]:
pk+1c,j (s) = λc p
k,n+1
c,j (s) + (1− λc) pkc,j(s), s ∈ [0, Lj], j = LA, . . . ,LV,
pk+1t,i (z) = λt p
k,n+1
t,i (z) + (1− λt) pkt,i(z), z ∈ [zi,1, zi], i = 1, . . . , 6
(4.55)
– Compute qk+1/2j (s) and S
k+1/2
i with equations (4.46) and (4.48), respec-
tively, using the values pk+1c,j and p
k+1
t,i
– Update q and S using the relaxation method with parameters λq and λS
∈ (0, 1]
qk+1j (s) = λq q
k+1/2
j (s) +
(
1− λq
)
qkj (s), s ∈ [0, Lj], j = LA, . . . ,LV,
Sk+1i = λS Sk+1/2i + (1− λS)Ski , i = 1, 3;
(4.56)
• Step 12: Check convergence:
e(pk+1c , p
k
c ) = max
j=LA,...,LV
[
maxs∈[0,Lj ] |pk+1c,j (s)− pkc,j(s)|
maxs∈[0,Lj ] |pk+1c,j (s)|
]
< φc (4.57)
e(pk+1t , p
k
t ) = max
i=1,...,6
[
maxz∈[zi−1,zi] |pk+1t,i (z)− pkt,i(z)|
maxz∈[zi−1,zi] |pk+1t,i (z)|
]
< φt (4.58)
e(qk+1, qk) = max
j=LA,...,LV
[
maxs∈[0,Lj ] |qk+1j (s)− qkj (s)|
maxs∈[0,Lj ] |qk+1j (s)|
]
< φq (4.59)
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e(Sk+1,Sk) = max
i=1,3
 |Sk+1i − Ski |
|Sk+1i |
 < φS ; (4.60)
• Step 13: If (4.57), (4.58), (4.59), and (4.60) are verified then pk+1c,j (s) and
pk+1t,i (z), for s ∈ [0, Lj], j = LA, . . . ,LV, z ∈ [zi−1, zi], i = 1, . . . , 6, are the
solution of the system. If not all of the conditions in Step 13 are verified, then
set k = k + 1 and return to Step 2.
4.5 Preliminary results and discussion
Numerical simulations are run to test the model outcomes in the control state,
which corresponds to the condition of a healthy individual. At this stage, the model
does not include any autoregulation mechanism and the level of retinal blood flow is
fixed to the healthy value of Q = 6.08 · 10−4 mL/s obtained from the coupled model
(Chapter 3).
The model predictions of partial pressure of oxygen in the blood pc, blood oxygen
saturation SO2 in the six compartments of the microvasculature, and partial pressure
of oxygen in the retinal tissue Layers 1− 6 are depicted in Figure 4.5, Figure 4.6, and
Figure 4.7, respectively.
The qualitative distribution of blood oxygen saturation is analogous to the results
in [45, 131] that show a steep decrease in saturation in the capillary compartment.
The value of venous oxygen saturation predicted by the model is 61% and is consistent
with the value of 60%± 5.7% measured in [32] (Figure 4.5).
The partial pressure of oxygen and the oxygen saturation in the two capillary
compartments show a slightly different behavior (Figure 4.5b and 4.6b) due to the
diverse level of oxygen partial pressure in the tissue Layers 1 and 3 (Figure 4.7).
The model predictions of tissue oxygen partial pressure (Figure 4.7) are in agree-
ment with previous model results in [127].
The improved vascular architecture and oxygen exchange condition in the model
allows a heterogeneous distribution of oxygen in the two capillary compartments as
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Figure 4.5. (a) Model predictions of blood oxygen partial pressure
as a function of position in the network in the six compartments
LA,SA,C1,C3,SV,LV at control state.(b) Blood oxygen partial pressure
as a function of position in the network in the C1 and C3 compartments.
shown in Figure 4.5b and 4.6b, dictated by the local oxygen source and consumption
in the different retinal layers. Furthermore the improved retinal anatomy adds ad-
ditional levels of detail to the descriptive ability of the model, allowing for separate
contributions of the inner and outer retina.
Even though the results presented here are preliminary, they stress the impor-
tance of the improvements introduced by the retinal anatomy, vascular architecture
and oxygen exchange in the model. Thus, the coupling between this model, the au-
toregulatory mechanisms introduced in Chapter 3, and the macrocirculation model
introduced in Chapter 2 could help to interpret the outcomes of clinical studies and
lead to a better understanding of ocular diseases.
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Figure 4.6. (a) Model predictions of blood oxygen saturation as a function
of position in the network in the six compartments LA,SA,C1,C3,SV,LV
at control state. (b) Blood oxygen saturation as a function of position in
the network in the C1 and C3 compartments.
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Figure 4.7. Model predictions of tissue oxygen partial pressure distribu-
tion in the six retinal layers in Figure 4.1.
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5. MATHEMATICAL MODELING OF AQUEOUS HUMOR
FLOW
IOP is an important input parameter in the models presented in Chapters 2 and 3. In
those models, the value of IOP is set a priori and is varied to define different clinical
states. These models did not include the various factors within the eye that combine
to yield a specific IOP value. In this Chapter, we move a first step towards the study
of the multiple mechanisms that contribute to determine the IOP level.
The flow of AH inside the eye plays an important role in determining the level of
IOP [137–139]. Thus, we compute IOP as the solution of a simplified mathematical
model describing the balance between AH production and drainage; we then perform
a sensitivity analysis to quantify the influence of variations in physiological parameters
on the IOP level in different situations of clinical interest. The model accounts for the
variability of these parameters in a systematic manner in order to identify patient-
specific factors that may influence the efficacy of IOP-lowering medications, with the
ultimate goal of contributing to the development of novel, effective, and individualized
therapeutic approaches in glaucoma management.
In Section 5.1 we describe the model and its governing equations. In Section 5.2
we present the model results for four different clinical cases of medical interest. In
Section 5.3 we discuss and interpret the model outcomes, comparing them with the
results of different clinical studies.
The material and results presented in this Chapter are partially published in [140].
5.1 Methods
To analyze AH flow, we implement a mathematical model that describes the steady
state value of IOP as the result of the balance between AH production and drainage.
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J
IOP
Guv
EVP
Gtm
Figure 5.1. Network model for production and drainage of aqueous humor.
Changes in ocular blood volume, mainly localized in the choroid, are conjectured to
affect the time variations of IOP [138], but they are not considered here.
The flow Q of AH is described using the analogy between the flow of a fluid
in a hydraulic network and the flow of a current in an electric circuit, depicted in
Figure 5.1. Variable conductances are indicated with an arrow.
The flow of AH Q through a conductor is described using Ohm’s law:
Q = G∆P, (5.1)
where the conductance G (= 1/R, reciprocal of resistance) represents the ability to
allow the passage of fluid through a physiological pathway, and ∆P represents the
pressure drop along that pathway.
The contribution of protein and low-molecular components to AH production is
included in the model through a current source of intensity equal to J , which thus
represents an AH flow rate.
AH is produced at the level of the ciliary body by a combination of a passive
mechanism (the ultrafiltration) and an active mechanism (the ionic secretion) and
is modulated by the total inflow facility Gin [137, 139, 141]. Here, the term facility
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indicates hydraulic conductance, namely a flow rate per units of pressure. The total
flow Jin of AH entering the eye is given by
Jin = Juf + Jsecr, (5.2)
where Juf and Jsecr are the flows due to ultrafiltration and active secretion, respec-
tively. The ultrafiltration from the ciliary circulation consists of flow of transparent
fluid across semipermeable membranes (including vascular walls, stroma and epithe-
lial cells) and is driven by differences in hydrostatic pressures (cBP-IOP), where cBP
is the blood pressure in the capillaries of the ciliary body, and oncotic pressures (∆Πp)
modulated by a protein reflection coefficient (σp). We thus write Juf as
Juf = Gin
[
(cBP− IOP)− σp∆Πp
]
. (5.3)
The inflow due to active ionic secretion is proportional to the blood/AH osmotic
pressure difference (∆Πs) via a reflection coefficient for low-molecular components
(σs), and it is similarly written as
Jsecr = Gin [−σs∆Πs] . (5.4)
Thus, the value of AH flow generated by J (Figure 5.1) is equal to
J = −Ginσp∆Πp + Jsecr = −Gin
(
σp∆Πp + σs∆Πs
)
. (5.5)
The drainage of AH from the eye is driven by passive mechanisms through two
different pathways. The trabecular pathway, also known as the conventional pathway,
consists of AH flow through the trabecular meshwork into the Schlemm’s canal and
the episcleral veins. The uveoscleral pathway, also known as the non-conventional
pathway, consists of AH flow through the ciliary muscle and into the supraciliary
space. Thus, the total flow Jout of AH leaving the eye is given by
Jout = Jtm + Juv, (5.6)
where Jtm and Juv are the flows via the trabecular and uveoscleral pathways, re-
spectively. As proposed by Brubaker [142], the trabecular pathway model consists
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of flow through a nonlinear resistor positioned between the anterior chamber (where
the pressure is equal to IOP) and the episcleral veins (where the pressure is equal to
the episcleral venous pressure (EVP)) with outflow facility Gtm, and is given by the
following equation:
Jtm = Gtm(IOP− EVP), with Gtm = 1
R0
[
1 + Θ (IOP− EVP)] , (5.7)
where R0 is the resistance when IOP equals EVP, and Θ is the outflow obstruction co-
efficient. The contribution of the uveoscleral pathway is modeled as the flow through
a nonlinear resistor connected to the ground [139], with outflow facility Guv depending
nonlinearly on the pressure through a Michaelis-Menten type relation [143]:
Juv = Guv(IOP− 0), with Guv = k1
k2 + IOP
, (5.8)
where k1 is the maximum value attainable by the uveoscleral flow rate and k2 is the
Michaelis constant for the uveoscleral flow rate, namely the pressure value for which
the uveoscleral flow rate is half of k1.
The value of the pressure at the internal node of the system depicted in Figure 5.1
corresponds to the value of IOP. The steady state value of IOP, resulting from the
balance between production and drainage of AH, namely Jin = Jout, can be written
as:
Juf + Jsecr = Jtm + Juv, (5.9)
or, equivalently:
Gin
[
(cBP− IOP)− σp∆Πp − σs∆Πs
]
=
=
1
R0
[
1 + Θ (IOP− EVP)](IOP− EVP) + k1k2 + IOPIOP. (5.10)
This is a scalar third-order polynomial equation in one unknown, IOP, that can be
found explicitly. Control state values for the parameters, defined to represent typical
conditions of a healthy eye, are indicated with an overline bar in Table 5.1.
To include potential sources of uncertainties as well as to identify and rank pa-
rameters having the most important influence on IOP, we applied a global stochastic
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Table 5.1.
Control state values for the parameters in the model for aqueous humor
flow in equation (5.10).
Parameter Value Source
Total inflow facility Gin,
µL
min mmHg
0.3 [141]
Blood pressure in the capillaries
27.5 [138,139,141]
of the ciliary body cBP, mmHg
Blood/AH oncotic pressure difference ∆Πp, mmHg 25 [141]
Reflection coefficient for proteins σp 1 [141]
Blood/AH osmotic pressure difference ∆Πs, mmHg −450 [141]
Reflection coefficient for low-molecular components σs 0.0515 [141]
Episcleral venous pressure EVP, mmHg 8 [139]
Trabecular outflow resistance
2.2 [142]
(when pressure gradient equals 0) R0, mmHg min/µL
Trabecular outflow obstruction coefficient Θ, mmHg−1 0.012 [142]
Maximum uveoscleral flow rate k1, µL/min 0.4 [139]
Pressure at which uveoscleral flow rate
5 [139]
is at half maximum k2, mmHg
sensitivity analysis to the model described above. We considered stochastic varia-
tions in cBP following a normal distribution, and in Gin, ∆Πs, G0 = 1/R0, k1 and
EVP following a uniform distribution. By using the probability distribution of IOP,
we computed variance-based sensitivity indices, also known as Sobol indices [144],
and the probability density function [145], which describes the relative frequency of
a given IOP value. In sensitivity analysis, Sobol indices explain the importance of an
input factor on the variance of the output (that corresponds to the level of IOP). For
each parameter, its direct influence on IOP is quantified in terms of first-order Sobol
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indices, and the influence through interactions with other parameters is identified
by means of the total Sobol indices. The values of first-order and total indices can
be estimated via Monte Carlo simulations [144], or via reduced order models using
polynomial chaos expansion [146]. The former method is very costly from the com-
putational viewpoint as it requires many evaluations to ensure convergence, whereas
the latter requires considerably less evaluations. Both methods have been compared
and provide similar results. Here, we show the results obtained using the polynomial
chaos reduced model.
5.2 Results
The model is used to compute the IOP distribution in four different cases of clini-
cal interest: (i) ocular normotensive healthy subjects (ONT); (ii) ocular hypertensive
subjects (OHT); (iii) ONT subjects treated with IOP-lowering medications (ONTm);
and (iv) OHT subjects treated with IOP-lowering medications (OHTm). The IOP
probability density function and first and total Sobol indices are reported in Fig-
ure 5.2 for the four cases. Mean values, standard deviations, and skewness of the
IOP distribution in the four cases are reported in Table 5.2. Model simulations and
results are described below.
(i) ONT subjects. The mean values of cBP, Gin, ∆Πs, G0, k1 and EVP are set equal
to their control state values and are summarized in Table 5.1. Variations in cBP
are deduced from variations in MAP. Specifically, we write cBP= αMAP, where
α = 0.296 is chosen as to obtain cBP= 27.5 mmHg when MAP= 93 mmHg; we
assumed a normal distribution for MAP of 93± 7.6 mmHg [148]. Variations in
Gin, ∆Πs, G0, k1 and EVP are assumed to follow a uniform distribution with a
variation of 15% with respect to their control state values.
Simulation outcomes: The IOP probability density function for ONT subjects
(Figure 5.2a) fits a right-skewed Gaussian curve with a frequency peak of 25% at
15.13 mmHg and a skewness of 0.2, which is in a very good agreement with the
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Table 5.2.
Mean values, standard deviations and skewness of the distribution of in-
traocular pressure (IOP) resulting from the sensitivity analysis of the
mathematical model in equation (5.10) for four cases of clinical interest.
Clinical cases IOP, mmHg
Skewness of IOP
distribution
Ocular normotensive (ONT) 15.13± 1.58 0.2
Ocular hypertensive (OHT) 20.12± 2.35 0.09
Ocular normotensive treated with
12.58± 1.32 0.17
IOP-lowering medications (ONTm)
Ocular hypertensive treated with
15.81± 2.03 0.08
IOP-lowering medications (OHTm)
results from a population-based study on approximately 12, 000 subjects [147]
(green curve in Figure 5.2a). The results for the Sobol indices (Figure 5.2b)
suggest that IOP is strongly influenced by cBP and ∆Πs and mildly influenced
by the levels of Gin, G0 and EVP. The influence of k1 on IOP appears to be
minimal.
(ii) OHT subjects. OHT condition is simulated by decreasing the mean value of the
trabecular meshwork outflow facility as suggested by several clinical observa-
tions [149, 150]. Thus, here we set G0 = 0.3G0, leaving the mean values of the
other parameters at control state values.
Simulation outcomes: IOP probability density function in the OHT case (Fig-
ure 5.2c) fits a Gaussian curve, but with a frequency peak of 15% at 20.12 mmHg
and with a more symmetric profile than the ONT Gaussian curve (skewness =
0.09). The Sobol indices values for OHT subjects (Figure 5.2d) show a stronger
dependence of IOP on cBP and ∆Πs and a weaker dependence of IOP on Gin,
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G0 and EVP than for ONT subjects. The influence of k1 on IOP remains
minimal.
(iii) ONT subjects treated with IOP-lowering medications (ONTm). We model the
effect of IOP-lowering medications by reducing the active ionic secretion by
25%, which sets the mean value of the blood/AH osmotic pressure difference
to = 0.75∆Πs; the mean values of the other parameters remained at control
state. This modeling choice is justified by the fact that the sensitivity analyses
in both the ONT and OHT cases have identified ∆Πs as an important determi-
nant of IOP levels; in addition, clinical evidence and studies also support this
notion [137–139].
Simulation outcomes: The IOP probability density function in the ONTm case
(Figure 5.2e) fits a right-skewed Gaussian curve with a frequency peak of 30% at
12.58 mmHg and a skewness of 0.08. Thus, our simulations predict a reduction
of 2.55 mmHg in the mean value of IOP when IOP-lowering medications are
administered to ONT subjects. The results of the Sobol indices (Figure 5.2f)
suggest that IOP is strongly influenced by cBP and ∆Πs and mildly influenced
by the levels of Gin, G0 and EVP. The influence of k1 on IOP is again minimal.
(iv) OHT subjects treated with IOP-lowering medications (OHTm). We simultane-
ously account for OHT conditions and IOP-lowering treatment by setting the
mean values of G0 and ∆Πs to G0 = 0.3G0 and ∆Πs = 0.75∆Πs, leaving the
mean values of the other parameters at control state values.
Simulation outcomes: IOP probability density function in the OHTm case (Fig-
ure 5.2g) fits a Gaussian curve with a frequency peak of 20% at 15.81 mmHg
and has a more symmetric profile than the curve in the ONTm case (skewness
= 0.08). Thus, our simulations predict a reduction of 4.31 mmHg in the mean
value of IOP when IOP-lowering medications are administered to OHT sub-
jects. The results on Sobol indices (Figure 5.2h) are similar to those obtained
in the ONTm case, but with a weaker contribution of Gin, G0 and EVP.
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Our results demonstrate that first-order and total Sobol indices do not present notice-
able differences in any of the four simulated scenarios, suggesting that higher order
interactions among the selected factors are minimal.
5.3 Discussion
The model reproduced conditions of normal ocular tension, with blood pressure
and IOP values within physiological ranges, and was subsequently used to simulate
the effect of IOP-lowering medications. The proposed model suggests that the out-
comes of IOP-lowering treatments depend on the initial IOP level of the patient and
on the patient’s individual clinical condition. Specifically, the model predicts mean
IOP reductions of 2.55 mmHg and 4.31 mmHg when the pre-treatment IOP mean
values are 15.13 mmHg and 20.12 mmHg, respectively. These predictions are in good
agreement with Rulo et al. [151] who reported mean IOP reductions of 2 mmHg and
4.2 mmHg for pre-treatment IOP mean values of 15.3 mmHg and 18.4 mmHg, re-
spectively. However, it is important to remark that the study by Rulo et al. utilized
Latanoprost, a prostaglandin analog that increases AH drainage, whereas we modeled
IOP-lowering medications by decreasing AH production. Other studies reported IOP
reductions ranging from 3 mmHg to 4.4 mmHg in response to brinzolamide [152],
from 4.5 mmHg to 6.1 mmHg in response to dorzolamide [153], and from 2.4 mmHg
to 4.5 mmHg in response to Latanoprost [154]. The mean IOP reductions reported
in these studies [155] are close or slightly higher than those predicted by our model;
this might be due to the fact that these studies started from higher pre-treatment
IOP levels (ranging from 23.8 mmHg to 28.9 mmHg) than those considered in our
simulations.
Our analysis also suggests that IOP-lowering effects are more pronounced when
AH production is affected rather than AH drainage. The effects of lowering IOP are
also more apparent when trabecular outflow is increased instead of the uveoscleral
outflow. Another interesting finding of our analysis is that a patient’s blood pres-
114
sure strongly influences the outcomes of IOP-lowering treatments, which may explain
why the effect of some drugs differ between day-time and night-time and/or among
individuals [151,154,156,157]. A further investigation that incorporates a theoretical
model coupling AH production and drainage with ocular blood flow may lead to a
better understanding of this delicate, yet important, relationship [46,139,158].
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Figure 5.2. Probability density function of intraocular pressure (IOP)
(left figures), and Sobol indices resulting from the sensitivity analysis per-
formed on the mathematical model of equation (5.10) when variations in
ciliary capillary blood pressure cBP, total inflow facility Gin, blood/AH
osmotic pressure difference ∆Πs, trabecular outflow facility G0, uveoscle-
ral outflow facility k1 and episcleral venous pressure EVP are considered
(right figures). The model predictions are obtained for the clinical cases
ONT, OHT, ONTm, OHTm.
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6. CONCLUSIONS
In this thesis, mathematical models for the retinal circulation, the transport of oxygen
in the retina, and the production and drainage of AH are proposed. Summarizing:
• We developed a compartmental time-dependent mathematical model for the
retinal circulation that accounts for blood flow in the central retinal vessels
and microvasculature, vascular regulation, and the effect of IOP on the retinal
vasculature. The model has been used to compute the values of retinal blood
flow, blood velocity and pressure distribution in the retinal vasculature for six
theoretical patients with different clinical conditions. The model results have
been compared with clinical data to clarify the impact of changes in IOP, BP
and AR on retinal hemodynamics. The model has been directly applied to the
interpretation of the outcomes of trabeculectomy (Chapter 2).
• We used mathematical methods to describe the difference between compressible
and collapsible tubes and implemented these methods to describe the passive
resistances of the CRA, venules and CRV compartments (Section 2.1.5).
• We proposed a coupling between the model described in Chapter 2 and the
mechanistic model for autoregulation in [45]. The coupling introduced the
Krogh-cylinder type model for the diffusion of oxygen from the retinal vas-
culature into the retinal tissue and four vascular regulation mechanisms that
substituted the phenomenological approach used in Chapter 2. This improved
model has been used to predict the level of tissue oxygenation for alterations
in BP and tissue oxygen demand. Furthermore the model predictions revealed
the relative importance of the different regulation mechanisms to achieve VR
(Chapter 3).
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• We improved the description of the transport of oxygen in the retinal microvas-
culature and retinal tissue by including a more physiological representation of
retinal anatomy, vascular architecture and oxygen exchange in Chapter 4. The
preliminary results obtained with this model for oxygen blood saturation in the
retinal microvasculature and partial pressure of oxygen in the retinal tissue are
in good agreement with the literature.
• We implemented a mathematical model that describes the production and
drainage of AH, which affect the level of IOP. A sensitivity analysis was pre-
formed to quantify the effect of some physiological parameters on the IOP
distribution in theoretical patients of clinical interest and to understand the
uncertainty of the outcomes of clinical studies on the effect of IOP-lowering
medications.
The interpretation of the model results contributes to answer the following ques-
tions of clinical relevance:
How do IOP variations affect retinal hemodynamics?
The model predictions in Chapter 2 show that the hemodynamic response of the
system to changes in IOP varies depending on the level of BP and the functionality
of AR. The AR plateau is influenced by the level of BP, occurring for higher values of
pressure for hypertensive individuals. Thus, different values of retinal blood flow can
correspond to the same value of IOP depending on the level of BP and functionality
of AR. The model results for CRA blood velocity suggest that the same reduction in
IOP can lead to small or large changes in velocity depending on the initial value of
IOP.
In addition, the model predictions show that, for some theoretical patients, the
IOP-interval for which the retinal blood flow is almost constant does not overlap with
the IOP-interval where PSV and EDV are almost constant. This results is interesting
because, in clinical studies, the measured value of velocity is used as a surrogate to
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compute the level of blood flow. However, the model results show that in some cases
this will not yield an accurate estimate of the trends in retinal blood flow.
The model predictions for trabeculectomy give a similar picture, in which the out-
comes of a decrease in IOP strongly depend on the level of BP and AR functionality
of the patient.
What is the effect of collapsible tubes?
The collapsibility of veins plays a significant role on the pressure distribution in the
system. As IOP increases, the CRV and the venules compartments collapse, causing
an increase in the upstream pressure. This passive feedback mechanism, consistent
with experimental observations, helps the retinal microvasculature to withstand the
increased IOP and improves the level of perfusion.
What is the effect of the coupling with [45] and what mechanisms play
a major role in vascular regulation?
The results in Chapter 3 stress the importance of coupling the macrocirculation
model with the microcirculation model. Although the coupled and microcirculation
models have a similar behavior in the range of pressures where VR works properly,
the results notably differ outside this range. This suggests that the coupled model
provides a more comprehensive and accurate depiction of hemodynamics in the retina
than the sole microcirculation model. When comparing the contribution of the vas-
cular regulation mechanisms, the model highlights the importance of the metabolic
and CO2 responses. Impairing either of these mechanisms could cause insufficient tis-
sue oxygenation and therefore ischemic damage. The model also predicts that blood
flow will increase more for an increase in tissue oxygen demand than for the same
percentage decrease in O2 demand.
How does retinal anatomy, vascular architecture and oxygen exchange
affect tissue oxygenation?
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The model derived in Chapter 4 includes a heterogeneous description of the retinal
tissue, adapts the vascular network to accommodate for two distinct levels of capil-
laries, and introduces a new model for the exchange of oxygen between retinal tissue
and vasculature that responds to local changes in oxygen partial pressure. This more
realistic tissue/vascular architecture, together with the improved model for oxygen
exchange, isolate the contributions of the inner and outer retina in the oxygen profiles
predicted by the model, enhancing the model’s predictive ability.
What are the major factors influencing the level of IOP?
The statistical analysis performed in Chapter 5 suggests that the inconsistencies
of the effect of IOP-lowering medication might depend on the level of IOP before
the medicine was administrated. Furthermore a greater decrease in IOP is predicted
when the medicine affects AH production rather then AH drainage. The statistical
analysis reveals that BP is one of the primary factors that influences the value of IOP,
which might explain the difference in effectiveness of medications among individuals.
What insight can mathematical modeling provide to clinicians?
The results of this thesis demonstrate that mathematical modeling can be used
alongside clinical and animal studies as (i) a tool to understand the complex relation-
ship among different factors at play, (ii) a virtual lab where theories and treatments
can be tested on theoretical patients and guide clinical developments, and (iii) an
instrument to quantify or estimate factors that are difficult or impossible to measure.
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